COVID-19 Evidence Reviews
as of 5/14/21
menu
 
 

Clinical Characteristics
 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
5/7/21
Gulsen A, Konig I, Jappe U, et al. | Respirology
Aim: To examine in detail whether the underlying chronic obstructive pulmonary diseases (COPD), asthma and chronic respiratory diseases (CRDs) were associated with an increased risk of more severe COVID-19. 
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Mutiawati E, Syahrul S, Fahriani M, et al. | F1000Res
Aim: To determine the prevalence of headache in coronavirus disease 2019 (COVID-19) and to assess its association as a predictor for COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Aladawi M, Elfil M, Abu-Esheh B, et al. | Can J Neurol Sci
Aim: To review the evidence on the association between Guillain Barre Syndrome and COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Dembrovszky F, Váncsa S, Farkas N, et al. | Viruses
Aim: To evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. 
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Aldien AS, Ganesan GS, Wahbeh F, et al. | Cardiovasc Revasc Med
Aim: To investigate the possible role of hyperinflammation in inducing cardiac injury as one of the severe complications of COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Lu Y, Zhao J, Ye M, et al. | Neurol Sci
Aim: To determine the risk of acute ischemic stroke in patients with severe and non-severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/7/21
Cosco TD, Best J, Davis D, et al. | Age Aging
Aim: To quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/6/21
Angelico R, Blasi F, Manzia TM, et al. | Medicina
Aim: To investigate the current management of IS therapy in KT recipients with COVID-19. 
CLINICAL CHARACTERISTICS
5/5/21
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
5/5/21
Li X, Zhong X, Wang Y, et al. | PLoS One
Aim: To systematically identify the possible risk factors responsible for severe cases.
CLINICAL CHARACTERISTICS
5/5/21
Rehman MA, Farooq H, Ali MM, et al. | SN Compr Clin Med
Aim: To identify cases of subacute thyroiditis associated with COVID-19 and evaluated patient-level demographics, major clinical features, laboratory findings and outcomes.
CLINICAL CHARACTERISTICS
5/4/21
Du P, Li D, Wang A, et al. | Can J Infect Dis Med Microbiol
Aim: To screen the risk factors for severe illness and death and provide help for early clinical treatment of the new coronavirus (COVID-19).
CLINICAL CHARACTERISTICS
5/4/21
Dos Santos ACM, Dos Santos BRC, Dos Santos BB, et al. | Infect Genet Evol
Aim: to review the effect of single nucleotide polymorphisms in the development of severe acute respiratory syndrome (SARS).
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/4/21
Hariyanto TI, Rosalind J, Christian K, et al. | South Afr J HIV Med
Aim: To explore the impact of HIV and SARS-CoV-2 co-infection on mortality.
CLINICAL CHARACTERISTICS
5/4/21
Nepal G, Shrestha GS, Rehrig JH, et al. | J Nepal Health Res Counc
Aim: To review the evidence on neurological involvement in COVID-19 associated MIS-C.
CLINICAL CHARACTERISTICS
5/4/21
Liang M, Luo N, Chen M, et al. | Infect Dis Ther
Aim: To investigate the prevalence and mortality in PLWHA co-infected with COVID-19.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/3/21
Mogensen MA, Wangaryattawanich P, Hartman J, et al. | Br J Radiol
Aim: To describe outcomes associated with abnormal neuroimaging findings among adult COVID-19 patients.
CLINICAL CHARACTERISTICS
4/30/21
Lee J, Song J | J Med Virol
Aim: To investigate the diagnostic accuracy of the Xpert Xpress and the ID NOW assays for rapid detection of SARS-CoV-2.
CLINICAL CHARACTERISTICS
4/30/21
Peiris S, Mesa H, Aysola A, et al. | PLoS One
Aim: To summarize the reported pathologic findings on biopsy and autopsy in patients with severe/fatal COVID-19 and documented the presence and/or effect of SARS-CoV-2 in all organs.
CLINICAL CHARACTERISTICS
4/29/21
Choudary MC, Crain CR, Qiu X, et al.  | Clin Infect Dis
Aim: To characterize the hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.
UPDATED
CLINICAL CHARACTERISTICS
4/28/21
Hayward SE, Deal A, Cheng C, et al. | J Migr Health
Aim: To assess clinical outcomes of COVID-19 in migrant populations (cases, hospitalisations, deaths), indirect health and social impacts, and to determine key risk factors.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Sheikh AB, Chourasia PK, Javed N, et al. | J Neuroimmunol
Aim: To determine demographic characteristics, clinical features, lab evaluation, management and complications of the studies focusing on Guillain-Barre syndrome (GBS) as a sequele of novel coronavirus (COVID-19) infection.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Yu J, Wu B, Feng L, et al. | J Tissue Viability
Aim: To summarize the pressure injuries caused by COVID-19 and the corresponding preventive measures and treatments.
CLINICAL CHARACTERISTICS
4/27/21
Mitaka H, Kuno T, Takagi H, et al. | Mycoses
Aim: To determine the incidence and mortality of CAPA in critically ill patients with COVID-19 to improve guidance on surveillance and prognostication.
CLINICAL CHARACTERISTICS
4/27/21
Patralekh MK, Jain V, Iyengar K, et al.  | J Clin Orthop Trauma
Aim: To evaluate the impact of COVID-19 on patients with PFF and assessed associated mortality.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Wu Y, Li H, Zhang Z, et al. | Ann Palliat Med
Aim: To evaluate the in-hospital mortality and risk factors of death in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/26/21
Garcia-Zamora S, Lee S, Haseeb S, et al. | Pacing Clin Electrophysiol
Aim: To examine the prevalence of cardiac arrhythmias detected by the electrocardiogram and their relationships with adverse outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Ma Z, Wang MP, Liu L, et al. | Aging
Aim: To review the evidence on whether ACEI and/or ARB are associated with the risk of SARS-COV2 infection and whether they are associated with adverse outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Singh J, Malik P, Patel N, et al. | Clin Exp Med
Aim: To identify prevalence and association of comorbid chronic kidney disease (CKD), acute kidney injury (AKI) and utilization prevalence of continuous renal replacement therapy (CRRT) in COVID-19-hospitalized patients as a function of severity status. 
CLINICAL CHARACTERISTICS
4/26/21
Parsons N, Outsikas A, Parish A, et al. | AJNR Am J Neuroradiol
Aim: To quantitatively evaluate whether a network diffusion model can explain the spread of small neurologic events.
CLINICAL CHARACTERISTICS
4/26/21
Hariyanto TI, Kurniawan A | Sleep Med
Aim: To analyze the relationship between OSA and poor outcomes of COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Dmytriw AA, Chibbar R, Chen PPY, et al. | Expert Rev Respir Med
Aim: To review the evidence on the outcomes of patients with COVID-19-related ARDS compared to ARDS unrelated to COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Chong WH, Neu KP | J Hosp Infect
Aim: To discuss the incidence, characteristics, diagnostic criteria, biomarkers, and outcomes of hospitalized patients diagnosed with CAPA.
CLINICAL CHARACTERISTICS
4/26/21
Iwu CJ, Iwu CD, Wiysonge CS | Pan Afr Med J
Aim: To synthesize evidence on the long-term effects of the SARS-CoV-2 infection among survivors.
CLINICAL CHARACTERISTICS
4/22/21
Thakur B, Dubey P, Benitez J, et al.  | Sci Rep
Aim: To determine geographical, age, and gender related differences in the prevalence of comorbidities and associated severity and mortality rates among COVID-19 patients.
CLINICAL CHARACTERISTICS
4/22/21
Menon T, Sharma R, Saurabh K, et al.  | Cureus
Aim: To measure the prevalence of acute kidney injury (AKI) in COVID-19 and its association with the disease severity and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/21/21
Chowdhury AI, Alam MR, Rabbi MF, et al.  | Obes Med
Aim: To estimate the effects of overweight and obesity on COVID-19 disease severity.
CLINICAL CHARACTERISTICS
4/21/21
Medaglia AA, Siracusa L, Gioè C, et al.  | Ital J Pediatr
Aim: To review the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
4/21/21
Dy LF, Lintao RCV, Cordero CP, et al.  | Sci Rep
Aim: To estimate the proportion of COVID-19 patients with cardiac abnormalities and to determine the association between the cardiac abnormalities in COVID-19 patients and disease severity and mortality.
CLINICAL CHARACTERISTICS
4/20/21
Cheng MP, Cau A, Lee TC, et al.  | Crit Care Med
Aim: To compare the rates of cardiac injury by angiotensin-converting enzyme-2-binding viruses from viruses that do not bind to angiotensin-converting enzyme-2.
CLINICAL CHARACTERISTICS
4/20/21
Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R, et al.  | PeerJ
Aim: To understand the impact of COVID-19 on ADL performance of adult patients and to describe the common scales used to assess performance of ADL on patients post-COVID-19.
CLINICAL CHARACTERISTICS
4/20/21
Artemios A, Andreas L, Hadjigeorgiou L, et al. | Neurol Res
Aim: To characterize all – to date – reported cases with COVID-19 related myelopathy.
CLINICAL CHARACTERISTICS
4/20/21
Mondello C, Roccuzzo S, Malfa O, et al.  | Front Pharmacol
Aim: To review the main post-mortem findings reporting data on the infection effects on several organs.
CLINICAL CHARACTERISTICS
4/20/21
Parra-Medina R, Herrera S, Jaime M, et al. | Acta Haematol
Aim: To review cases in the literature about COVID-19 autopsies that reported microthrombi in different organs.
CLINICAL CHARACTERISTICS
4/17/21
Sing A, Hussain S, Antony B | Diabetes Metab Syndr
Aim: To systematically review the evidence on clinical outcomes in NAFLD patients with COVID-19.
CLINICAL CHARACTERISTICS
4/16/21
Akbar MR, Wibowo A, Pranata R, et al. | Front Nutr
Aim: To assess whether low serum 25-hydroxyvitamin D (25-OHD) level is associated with susceptibility to COVID-19, severity, and mortality related to COVID-19.
CLINICAL CHARACTERISTICS
4/16/21
Zuin M, Rigatelli G, Bilato C, et al. | J Interv Card Electrophysiol
Aim: To investigate the pooled prevalence of pre-existing AF and its short-term mortality risk in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/15/21
Kashetsky N, Mukovozov IM, Bergman J. | J Cutan Med Surg
Aim: To summarize reports of CLL coinciding with SARS-CoV-2 infection to clarify the prevalence, clinical relevance, and prognostic value of these lesions.
CLINICAL CHARACTERISTICS
4/14/21
Qi K, Zeng W, Ye M, et al. | Medicine
Aim: To describe the clinical, laboratory, and imaging characteristics of children with COVID-19 based on published data of pediatric COVID-19 cases.
CLINICAL CHARACTERISTICS
4/14/21
Mondal R, Deb S, Shome G, et al. | Mult Scler Relat Disord
Aim: To summarize so far available pieces of evidence documenting de novo novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) mediated spinal cord demyelinating diseases.
UPDATED
CLINICAL CHARACTERISTICS
4/14/21
Flook M, Jackson C, Vasileiou E, et al. | BMC Infect Dis
Aim: To review the evidence on the risk factors for severity, disease, and mortality for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Katoto PDMC, Brand AS, Bakan B, et al. | Environ Health
Aim: To review the evidence on whether exposure to acute and chronic air pollution influences the COVID-19 epidemiologic curve.
CLINICAL CHARACTERISTICS
4/13/21
Yao MQ, Zheng QX, Xu J, et al. | Zhejiang Univ Sci B
Aim: To summarize the demographical, clinical, and laboratorial characteristics of non-recurrence and recurrence groups.
CLINICAL CHARACTERISTICS
4/13/21
Handayani DR, Juliastuti H, Nawangsih EN, et al. | Obes Med
Aim: To assess the prognostic value of fasting hyperglycemia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Pranata R, Huang I, Lawrensia S, et al. | Pharmacol Rep
Aim: To address the current interest of whether the administration of PPI could increase the susceptibility and risk of poor outcome in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Hariyanto TI, Kurniawan A | Nutr Metab Cardiovasc Dis
Aim: To analyze the association between statin use and composite poor outcomes of COVID-19.
CLINICAL CHARACTERISTICS
4/13/21
Trimboli P, Camponovo C, Scappaticcio L, et al. | Rev Endocr Metab Disord
Aim: To review the evidence on thyroid dysfunction in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/12/21
Greyson SR, Auerbach AD, Mitchell MD, et al. | J Gen Intern Med
Aim: To review published guidance and collected discharge protocols and procedures to identify and synthesize common practices.
CLINICAL CHARACTERISTICS
4/12/21
Damayanthi HDWT, Prabani KIP | Arch Gerontol Geriatr
Aim: To identify the prevalence of malnutrition and levels of nutrients associated with outcomes of the older patients with COVID-19.
CLINICAL CHARACTERISTICS
4/12/21
Zhang Y, Cen M, Hu M, et al. | Clin Transl Gastroenterol
Aim: To evaluate the prevalence and the duration of shedding of fecal RNA in patients with COVID-19 infection.
CLINICAL CHARACTERISTICS
4/12/21
Palaiodimou L, Stefanou MI, Katsanos AH, et al. | Eur J Neurol
Aim: To critically appraise the published literature related to GBSs and COVID-19, and evaluate prevalence, clinical features and outcomes of GBSs in pateints with COVID-19 compared to non-COVID-19 contemporary or historical controls.
UPDATED
CLINICAL CHARACTERISTICS
4/12/21
Dhouib W, Maatoug J, Ayouni I, et al. | Syst Rev
Aim: To identify studies that recruited symptomatic patients, regardless of sex or age diagnosed with COVID-19, and calculated or estimated the incubation period between December 2019 and December 2020.
UPDATED
CLINICAL CHARACTERISTICS
4/8/21
Mutiawati E, Fahriani M, Mamada SS, et al. | F1000Res
Aim: To determine the global prevalence of anosmia and dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association with severity and mortality of COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
4/8/21
Saragih ID, Saragih IS, Batubara SO, et al. | Geriatr Nurs
Aim: To systematically examine the association between dementia and mortality among older adults with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/8/21
Islam MA, Kundu S, Alam SS, et al. | PLoS One
Aim: To conduct a systematic review and meta-analysis to estimate the overall pooled prevalence of fever and chills in addition to fever characteristics (low, medium, and high temperature) in both adult and paediatric COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/7/21
Saha S, Al-Rifai RH, Saha S | J Diabetes Metab Disord
Aim: To quantify the overall and subgroup weighted prevalence of mortality among diabetic (primary outcome) and non-diabetic (secondary outcome) and the weighted prevalence of DM (secondary outcome), in hospitalized COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/7/21
Zuin M, Rigatelli G, Bilato C, et al. | QJM
Aim: To perform a systematic review and meta-analysis of prevalence and mortality risk in COVID-19 patients with pre-existing dyslipidaemia.
CLINICAL CHARACTERISTICS
4/7/21
Camara AB, Brandao IA | Curr Med Chem
Aim: To study the receptor's family and functions most related to COVID-19 infection, also suggesting the tissue and cell location that the majority of COVID-19 receptors are mainly expressed.
CLINICAL CHARACTERISTICS
4/6/21
Alzahrani SH, Al-Rabia MW | Cardiol Res Pract
Aim: To assess the role of cardiac injury biomarkers measured on admission and during hospitalization as risk factors for subsequent death in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/6/21
Mardi P, Esmaeili M, Iravani P, et al. | Front Pediatr
Aim: To assess the demographic, laboratory, and clinical characteristics of children with KD-like syndrome during the COVID-19 pandemic and evaluate efficacy of treatments and patients' outcome. 
CLINICAL CHARACTERISTICS
4/6/21
Hoang T | Ann Glob Health
Aim: To examine the characteristics of repositive COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
4/6/21
Hariyanto TI, Kurniawan A | J Diabetes Metab Disord
Aim: To analyze the potential association between DPP-4 inhibitor and the composite poor outcome of COVID-19.
CLINICAL CHARACTERISTICS
4/6/21
Kollias A, Kyrikoulis KG, Lagou S, et al. | Vasc Med
Aim: To review the current evidence regarding the prevalence of VTE in patients with COVID-19 screened/assessed with lower limb ultrasonography or computed tomography pulmonary angiography.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Mirbeyk M, Saghazadeh A, Rezaei N | Arch Gynecol Obstet
Aim: To review the evidence concerning pregnant women with confirmed COVID-19 and their neonates.
CLINICAL CHARACTERISTICS
4/5/21
Kopanska M, Banas-Zabczyk A, Lagowska A, et al. | J Clin Med
Aim: To review the latest research on changes in EEG in patients with COVID-19 as a basis for further quantitative electroencephalogram (QEEG) diagnostics and EEG neurofeedback training. 
CLINICAL CHARACTERISTICS
4/5/21
Lee KW, Yap SF, Ngeow YF, et al.  | Int J Environ Res Public Health
Aim: To determine the epidemiological characteristics, clinical signs and symptoms, blood parameters, and clinical outcomes among PLHIV who contracted COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Chmielewska B, Barratt I, Townsend R, et al. | Lancet Glob Health
Aim: To assess the collective evidence on the effects on maternal, fetal, and neonatal outcomes of the pandemic.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Váncsa S, Dembrovsky F, Farkas N, et al.  | Viruses
Aim: To evaluate the clinical significance of repeatedly positive testing after coronavirus disease 2019 (COVID-19) recovery.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Wildwing T, Holt N | Ther Adv Chronic Dis
Aim: To summarize findings from a systematic overview of systematic reviews of the neurological symptoms seen in patients with COVID-19. 
CLINICAL CHARACTERISTICS
4/5/21
Zhao Y, Jin Y, Rao W, et al. | J Affect Disord
Aim: To compare the prevalence of psychiatric comorbidities in all subpopulations during the SARS and COVID-19 epidemics.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Marchi R, Sugita B, Centa A, et al. | Infect Genet Evol
Aim: To describe the role, function, and association of miRNAs in SARS-CoV-2 human infection and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Gisondi P, Di Leo S, Bellinato F, et al. | Dermatol Ther
Aim: To systematically review the studies reporting the time of onset of selected skin lesions with respect to the reported onset of the COVID-19 core symptoms.
UPDATED
CLINICAL CHARACTERISTICS
4/2/21
Zhao Y, Zhao L, Yang X, et al. | Rev Cardiovasc Med
Aim: To find the association between COVID-19 and cardiovascular complications. 
CLINICAL CHARACTERISTICS
4/1/21
Zhang X, Lewis AM, Moley JR | Sci Rep
Aim: To investigate the relationship between adverse COVID-19 outcomes and obesity.
CLINICAL CHARACTERISTICS
4/1/21
Baral R, Tsampasian V, Debski M, et al. | JAMA Netw Open
Aim: To conduct an updated and comprehensive systematic review and meta-analysis comparing mortality and severe adverse events (AEs) associated with receipt vs nonreceipt of ACEIs or ARBs among patients with COVID-19.
CLINICAL CHARACTERISTICS
4/1/21
Shi Y, Guo M, Yang W, et al. | Expert Rev Vaccines
Aim: To investigate the impact of SARS-CoV-2 on neurodegenerative diseases and the latest developments in COVID-19 vaccines.
CLINICAL CHARACTERISTICS
4/1/21
Yassin A, Nawaiseh M, Shaban A, et al.  | BMC Neurol
Aim: To address the neurological aspects of COVID-19 including NM, NC, and ND findings.
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Tang K, Hsu B, Chen D | Front Immunol
Aim: To review the evidence on the autoimmune and rheumatic manifestations associated with COVID-19.
CLINICAL CHARACTERISTICS
3/30/21
Aski BH, Anari AM, Choobdar FA, et al. | Int J Cardiol Heart Vasc
Aim: To systematically assess the incidence of such cardiac abnormalities due to MIS-C in children suffering Covid-19.
CLINICAL CHARACTERISTICS
3/30/21
Papadopoulos V, Koutroulos MV, Zikoudi DG, et al. | Diabetol Int
Aim: To examine diabetes-related acute metabolic emergencies in COVID-19 patients
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Kaminska H, Szarpak L, Kosior D, et al. | Acta Diabetol
Aim: To summarize and synthesize the evidence published about the impact of diabetes mellitus on in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/30/21
Peter HJ, Vancsa S, Ocskay K, et al. | Front Med
Aim: To evaluate if MAFLD or NAFLD are associated with a more severe disease course of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Vidale S | Cerebrovasc Dis
Aim: To describe the clinical features and etiological characteristics of ischemic stroke patients with CO-VID-19 infection.
CLINICAL CHARACTERISTICS
3/30/21
Iheanacho CO, Odili VU, Eze UIH | Futur J Pharm Sci
Aim: To systematically review available evidence for associations between exposure to RAAS inhibitors with susceptibility to SARS-CoV-2 infection and clinical outcomes in infected persons.
CLINICAL CHARACTERISTICS
3/30/21
Mahat RK, Panda S, Rathore V, et al. | Clin Epidemiol Glob Health
Aim: To evaluate the association of inflammatory parameters with the severity and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Petrelli F, Luciani A, Perego G, et al. | J Steroid Biochem Mol Biol
Aim: To assess the association between vitamin D and risk, severity, and mortality for COVID-19 infection.
CLINICAL CHARACTERISTICS
3/29/21
Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM, et al. | Eur J Clin Invest
Aim: To review the evidence on the relation of COVID-19 and thrombotic events and identify prognostic factors.
UPDATED
CLINICAL CHARACTERISTICS
3/29/21
Nahshon C, Segev Y, Schmidt M, et al. | J Chemother
Aim: To review the evidence on the outcomes of diagnosed COVID-19 cancer patients.
CLINICAL CHARACTERISTICS
3/29/21
Li Y, Ashcroft T, Chung A, et al. | J Glob Health
Aim: To synthesise all available evidence regarding the risk factors for poor outcomes in hospitalised COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/29/21
Gratz J, Miegele M, Maleczek M, et al. | Front Med
Aim: To provide robust estimates of clinically relevant VTE incidence rates in adult critically ill patients with COVID-19 together with estimates of bleeding rates.
CLINICAL CHARACTERISTICS
3/26/21
Cheng S, Zhao Y, Wang F, et al. | Medicine
Aim: To estimate the association of chronic comorbidities in severe and non-severe cases.
CLINICAL CHARACTERISTICS
3/26/21
Castiello T, Georgiopoulous G, Finocchiaro G, et al. | Heart Fail Rev
Aim: To review the challenges in the early diagnosis and management of myocarditis in patients with COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
3/26/21
Dubey P, Thakur B, Reddy S, et al. | BMC Pregnancy Childbirth
Aim: To review the evidence on any geographicaly differences in pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
3/25/21
Gerayeli FV, Milne S, Cheung C, et al. | EClinicalMedicine
Aim:  To determine whether COPD is a risk factor for poor outcomes in COVID-19, focusing on the specific endpoints of hospitalization, severe disease, and mortality.
UPDATED
CLINICAL CHARACTERISTICS
3/25/21
Kong X, Qi Y, Huang J, et al.  | Cancer Lett
Aim: To review the evidence on the prevalence of cancer in coronavirus disease 2019 (COVID-19)-infected patients and the severe illness incidence and mortality of COVID-19 patients with cancer.
UPDATED
CLINICAL CHARACTERISTICS
3/25/21
Hayashi Y, Wagatsuma K, Nojima M, et al. | J Gastroenterol
Aim: To undertake a systematic review and meta-analysis to determine whether the presence of gastrointestinal (GI) symptoms contributed toward COVID-19 severity, and identify the GI symptoms characteristic of severe COVID-19.
CLINICAL CHARACTERISTICS
3/24/21
Kasemi A, Mohammadi V, Aghababaee SK, et al. | Adv Nutr
Aim: To summarize and clarify the evidence on the association between 25(OH)D concentrations and COVID-19 risk and outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/24/21
Almufarrij I, Munro K | Int J Audiol
Aim: To systematically review the literature to December 2020, in order to provide a timely summary of evidence on SARS-CoV-2, COVID-19 and audio-vestibular symptoms.
UPDATED
CLINICAL CHARACTERISTICS
3/24/21
Longchamp G, Manzocchi-Besson S, Longchamp A, et al. | Thromb J
Aim: To systematically review and meta-analyze the risk of clinically relevant VTE in patients hospitalized for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/24/21
So M, Kabata H, Fukunaga K, et al. | BMC Pulm Med
Aim: To clarify the characteristics of radiological and functional lung sequelae of COVID-19 patients described in follow-up period.
CLINICAL CHARACTERISTICS
3/23/21
Artusi CA, Romagnolo A, Ledda C, et al. | J Parkinsons Dis
Aim: To assess whether the prevalence and outcome of COVID-19 in PD patients are different from those observed in the general population.
CLINICAL CHARACTERISTICS
3/23/21
Peng J, Wang Q, Mei H, et al. | Aging
Aim: To investigate the association between fungal co-infection and mortality due to COVID-19.
CLINICAL CHARACTERISTICS
3/23/21
Tiruneh SA, Tesema ZT, Azanaw MM, et al. | Syst Rev
Aim: To assess the pooled incidence of COVID-19 complications and to identify the association between the incidence of complications and age.
UPDATED
CLINICAL CHARACTERISTICS
3/23/21
Teshome A, Adane A, Girma B, et al. | Front Public Health
Aim: To summarize the available evidence regarding the association between Vitamin D levels and the risk of COVID-19 infection.
CLINICAL CHARACTERISTICS
3/22/21
Menon T, Sharma R, Earthineni G, et al. | Cureus
Aim: To measure whether GI manifestations warrant the testing for SARS-CoV-2 alone or in combination with lung manifestations and the association of GI manifestations with severe disease and mortality. 
CLINICAL CHARACTERISTICS
3/22/21
Ssentongo P, Heilbrunn ES, Ssentongo A, et al. | Sci Rep
Aim: To conduct a systematic review and meta-analysis of the prevalence of HIV in patients hospitalized for COVID-19 and delineating clinical outcomes including mortality.
UPDATED
CLINICAL CHARACTERISTICS
3/22/21
Zinellu A, Paliogiannis P, Carru C, et al. | Int J Infect Dis
Aim: To review the clinical implications of SAA concentrations in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/22/21
Dono F, Nucera B, Lanzone J, et al. | Epilepsy Behav
Aim: To summarize the available data on clinical features, diagnosis, and therapy of SE associated with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/22/21
Wei SQ, Bilodeau-Bertrand MB, Liu S, et al.  | CMAJ
Aim: To evaluate the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and adverse pregnancy outcomes.
CLINICAL CHARACTERISTICS
3/22/21
Zhao Y, Yin L, Jenil P, et al. | J Med Virol
Aim: To characterize inflammatory markers of MIS-C patients with COVID-19, Kawasaki disease (KD), and coronary artery abnormalities. 
UPDATED
CLINICAL CHARACTERISTICS
3/22/21
Barbalho SM, Matias JN, Flato UAP, et al. | Gastroenterology Res
Aim: To evaluate what influenza and COVID-19 may represent for patients with IBD.
CLINICAL CHARACTERISTICS
3/19/21
Zhang XM, Jiao J, Cao J, et al. | BMC Geriatr
Aim: To systematically review and quantify the results of the associations between frailty and mortality.
UPDATED
CLINICAL CHARACTERISTICS
3/18/21
Karimi L, Makvandi S, Vahedian-Azimi A, et al. | J Pregnancy
Aim: To investigate the effects of coronavirus disease 2019 (COVID-19) on mortality of pregnant and postpartum women.
CLINICAL CHARACTERISTICS
3/18/21
Cares-Marambio K, Montenegro-Jimenez Y, Torres-Castro R, et al. | Chron Respir Dis
Aim: To determine the prevalence of respiratory symptoms in survivors of hospital admission after COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
3/18/21
Giovanella L, Ruggeri RM, Ovcaricek PP, et al. | Clin Transl Imaging
Aim: To assess the prevalence of thyroid dysfunction in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/21
Hassib M, Hamilton S, Elkhouly A, et al. | Cureus
Aim: To assess whether ACEi/ARB use in patients with COVID-19 conferred worsened severity of illness or increased mortality.
CLINICAL CHARACTERISTICS
3/18/21
Kazemi E, Nejat RS, Ashkan F, et al. | Ann Clin Microbiol Antimicrobiol
Aim: To show the differences of laboratory findings of COVID-19 patients with different severity and survivability who had been admitted in hospital.
CLINICAL CHARACTERISTICS
3/16/21
Kaur A, Setia AS, Kashyap A, et al. | Eur J Mol Clin Med
Aim: To highlight the existing literature and organize data associating the mortality of coronavirus disease 2019 (COVID-19) in patients with and without asthma.
CLINICAL CHARACTERISTICS
3/16/21
Dalia T, Lahan S, Ranka S, et al. | Indian Heart J
Aim: To delineate the influence of various cardiac conditions (especially CHF) on outcomes of patients with COVID-19 and to determine the prognostic value of cardiac biomarkers — Troponin I, Creatine Kinase-MB (CK-MB), and N-terminal-proB-type Natriuretic Peptide (NT-proBNP).
CLINICAL CHARACTERISTICS
3/15/21
Mackey K, Arkhipova-Jenkins I, Armstrong C, et al. | Agency for Healthcare Research and Quality
Aim: To synthesize evidence on the prevalence, levels, and durability of the antibody response to SARS-CoV-2 infection among adults and how antibodies correlate with protective immunity.
CLINICAL CHARACTERISTICS
3/15/21
Allotey J, Stallings E, Bonet M, et al. | BMJ
Aim: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19).
UPDATED
CLINICAL CHARACTERISTICS
3/12/21
Oltean I, Tran J, Lawrence S, et al. | Heliyon
Aim: To illustrate findings in a narrative fashion pertaining to SARS-CoV-2 on placental pathology, maternal, and neonatal outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/11/21
Pellicori P, Doolub G, Wong CM, et al. | Cochrane Database Syst Rev
Aim: To assess the prevalence of pre?existing cardiovascular comorbidities associated with suspected or confirmed cases of COVID?19 in a variety of settings, including the community, care homes and hospitals. 
UPDATED
CLINICAL CHARACTERISTICS
3/11/21
Alkhathami M, Advani SM, Abalkhail AA, et al. | Lung India
Aim: To determine the prelavence and mortality of chronic lung diseases which include COPD, lung cancer, asthma, and cystic fibrosis in confirmed COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
3/11/21
Wang Q, Liu J, Shao R, et al.  | Rheumatol Int
Aim: To integrate data on the epidemiology of COVID-19 in the RD population and to analyze the risk of COVID-19 infection and its complications in RD patients compared with the general population.
UPDATED
CLINICAL CHARACTERISTICS
3/10/21
Kumar P, Jindal K, Aggarwal S, et al. | Indian J Orthop
Aim: To ascertain the impact of a co-existent infection on the 30-day mortality and inpatient mortality of patients with hip fractures including neck femur, intertrochanteric and subtrochanteric fractures. 
CLINICAL CHARACTERISTICS
3/10/21
Osman M, Klopfenstein T, Belfeki N, et al. | Viruses
Aim: To compare the clinical features and outcome, laboratory, and radiological findings of COVID-19 patients with influenza adult patients.
CLINICAL CHARACTERISTICS
3/10/21
Pal R, Banerjee M, Mukherjee S, et al. | Ther Adv Endocrinol Metab
Aim: To provide a precise summary of the effect of DPP4i use (preadmission or in-hospital) and mortality in COVID-19 patients with diabetes mellitus (DM).
UPDATED
CLINICAL CHARACTERISTICS
3/10/21
Hashan MR, Smoll N, King C, et al. | EClinicalMedicine
Aim: To define the epidemiology of COVID-19 outbreaks in RACFs to estimate the epidemiological index of the disease for these vulnerable populations.
UPDATED
CLINICAL CHARACTERISTICS
3/10/21
Gawronska K, Lorkowski J | Geriatr Orthop Surg Rehabil
Aim: To present the possible correlation between COVID-19 and diseases of the musculoskeletal system, in particular the occurrence of fall-related injuries.
CLINICAL CHARACTERISTICS
3/10/21
SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. | Arch Acad Emerg Med
Aim: To investigate the available evidence for long-term complications of COVID-19.
CLINICAL CHARACTERISTICS
3/10/21
Gallastegui N, Zhou JY, von Drygalski A, et al. | Clin Appl Thromb Hermost
Aim: To estimate the incidence of PE during hospitalization for COVID19 within and outside ICUs.
CLINICAL CHARACTERISTICS
3/8/21
Macedo A, Gonçalves N, Febra C, et al. | Ann Epidemiol
Aim: To evaluate the mortality of COVID-19.
CLINICAL CHARACTERISTICS
3/8/21
Peddapalli A, Gehani M, Kalle AM, et al. | Viruses
Aim: To review various mechanisms of excess immune response in adult COVID-19 patients
CLINICAL CHARACTERISTICS
3/8/21
Sarma P, Bhattacharyya A, Kaur H, et al. | Indian J Pharmacol
Aim: To evaluate the efficacy and safety of steroid therapy among all severity categories of patients with COVID-19 (mild to moderate and severe to critical category) in terms of "mortality," "requirement of mechanical ventilation," "requirement of ICU" and clinical cure parameters.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Shehab M, Alrashed F, Shuaibi S, et al. | BMJ Open Gastroenterol
Aim: To evaluate the prevalence of GI, liver function test (LFT) abnormalities, and mortality of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Booth A, Reed AB, Ponzo S, et al. | PLoS One
Aim: To systematically map all the available evidence on the association of various clinical, demographic, and lifestyle variables with the risk of specific adverse outcomes in patients with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Sansone P, Giaccari LG, Aurilio C, et al. | Life
Aim: To give a comprehensive overview of the demographic characteristics, clinical features, diagnostic investigations, and outcome of SARS-CoV-2-related GBS patients. 
CLINICAL CHARACTERISTICS
3/8/21
Jamshidi P, Hajikhani B, Mirsaeidi M, et al. | Front Med
Aim: To investigate the prevalence and characteristics of cutaneous manifestations in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Wibowo A, Pranata R, Akbar MR, et al. | Int J Infect Dis
Aim: To assess the prognostic value of elevated troponin above the 99th percentile upper reference limit (URL) on mortality and factors affecting their relationship.
CLINICAL CHARACTERISTICS
3/8/21
Akbar MR, Pranata R, Wibowo A, et al. | Diabetes Metab Syndr
Aim: To evaluate the association between the elevated CK and severity and mortality in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/7/21
Tondas AE, Mulawarman R, Trifitriana M, et al. | J Infect Dev Ctries
Aim: To investigate the electrocardiographic (ECG) ventricular repolarization indices in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/6/21
Li Z, Li X, Shen J, et al. | Environ Sci Pollut Res Int
Aim: To systematically review case reports on COVID-19-associated MFS, including the electrophysiological and clinical phenotypes.
CLINICAL CHARACTERISTICS
3/5/21
Sinclair JE, Zhu Y, Xu G, et al. | iScience
Aim: To analyze the association of host co-morbidities (chronic respiratory illnesses, cardiovascular disease [CVD], hypertension or diabetes mellitus [DM]) with the acute cardiovascular complications associated with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
3/5/21
Vahedian-Azimi A, Karimi L, Makvandi S, et al. | Adv Exp Med Biol
Aim: To investigate whether the causative agent of COVID-19 is found in semen. 
CLINICAL CHARACTERISTICS
3/5/21
Sheth A, Modi M, Dawson D, et al. | Sci Rep
Aim: To summarize the evidence regarding the prognostic relevance of cardiac biomarkers from data available in published reports.
CLINICAL CHARACTERISTICS
3/5/21
Makvandi S, Mahdavian M, Kazemi-Nia G, et al. | Adv Exp Med Biol
Aim: To report clinical symptoms, laboratory findings, and obstetrical complications, maternal, fetal, and neonatal complications of COVID-19 infection in pregnant women.
CLINICAL CHARACTERISTICS
3/5/21
Heidari-Beni F, Vahedian-Azimi A, Shojaei S, et al. | Adv Exp Med Biol
Aim: To investigate PCT levels in severe COVID-19 patients.
CLINICAL CHARACTERISTICS
3/4/21
Yang Y, Luo K, Jiang Y, et al. | J Nutr Health Aging
Aim: To synthesize the current studies to investigate impact of frailty on COVID-19 outcomes and provide evidence-based decisions in clinical practice.
CLINICAL CHARACTERISTICS
3/2/21
Simons D, Shahab L, Brown J, et al. | Addiction
Aim: To estimate the association of smoking status with rates of i) infection, ii) hospitalisation, iii) disease severity, and iv) mortality from SARS?CoV?2/COVID?19 disease.
UPDATED
CLINICAL CHARACTERISTICS
3/1/21
Sahranavard M, Rezayat AA, Bidary MZ, et al. | Arch Iran Med
Aim: To review the evidence on cardiac complications in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/1/21
Liang C, Zhang W, Li S, et al. | Med Clin
Aim: To search the association between coronary heart disease and the prognosis of COVID-19 patients.
CLINICAL CHARACTERISTICS
3/1/21
Willi S, Luthold R, Hunt A, et al. | Travel Med Infect Dis
Aim: To evaluate the available evidence of all intermediate and long-term COVID-19 sequelae affecting formerly healthy adults.
CLINICAL CHARACTERISTICS
3/1/21
Toba N, Gupta S, Ali AY, et al. | Pediatr Pulmonol
Aim: To understand the clinical characteristics of COVID-19 in children.
CLINICAL CHARACTERISTICS
3/1/21
Yang L, Chai P, Yu J, et al. | Cancer Biol Med
Aim: To investigate cancer incidence in patients with COVID-19 and to determine whether cancer was associated with mortality among patients with COVID-19.
CLINICAL CHARACTERISTICS
3/1/21
Samadder S | Front Public Health
Aim: To identify the possible cause of secondary pneumonia infection observed in COVID-19 patients.
CLINICAL CHARACTERISTICS
3/1/21
Tassone D, Thompson A, Connell W, et al. | Intern Med J
Aim: To determine whether immunosuppressed patients are at higher risk of COVID-19 to help inform the management of patients receiving immunosuppressant therapies during the pandemic.
CLINICAL CHARACTERISTICS
3/1/21
Zhou X, Cheng Z, Luo L, et al. | Thromb Res
Aim: To evaluate the prevalence of disseminated intravascular coagulation (DIC) in COVID-19 patients and to determine the association of DIC with the severity and prognosis of COVID-19.
CLINICAL CHARACTERISTICS
3/1/21
Tang Y, Li W, Baskota M, et al. | Transl Pediatr
Aim: To describe the clinical features, treatment and outcomes of MIS-C, as well as to assess the risk of bias of published case studies, analyzing their reporting quality.
CLINICAL CHARACTERISTICS
3/1/21
Poly TN, Islam M, Yang HC, et al. | Front Med
Aim: To evaluate the effect of obesity, associated comorbidities, and other factors on the risk of death due to COVID-19. 
CLINICAL CHARACTERISTICS
3/1/21
Aghili SMM, Ebrahimpur M, Arjmand B, et al. | Int J Obes
Aim: To clarify the obesity relationship with COVID-19 severity, comorbidities, and discussing possible mechanisms.
CLINICAL CHARACTERISTICS
3/1/21
Barlow-Pay F, Htut TW, Khezrian M, et al. | Ther Adv Drug Saf
Aim: To summarize the current international clinical guidelines to highlight areas where research is needed through critical appraisal of the evidence base of these guidelines.
CLINICAL CHARACTERISTICS
3/1/21
Naveed H, Elshafeey A, Al-Ali D, et al. | J Clin Pharmcol
Aim: To compare specific blood markers in both groups of COVID-19 patients in order to gain a better insight into the interaction of ACEi/ARBs with the different body functions during the infection.
CLINICAL CHARACTERISTICS
2/28/21
Karruli A, Spiezia S, Boccia F, et al. | Transpl Infect Dis
Aim: To assess the effect of continuing immune suppressive therapy in solid organ transplant recipients (SOTR) with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
2/26/21
Tan BK, Mainbourg S, Friggeri A, et al. | Thorax
Aim: To review the evidence on the prevalence of venous thromboembolic event (VTE) and arterial thromboembolic event (ATE) thromboembolic events in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/26/21
Mishra P, Parveen R, Bajpai R, et al. | Ann Acad Med Singap
Aim: To find the probable association between cardiovascular disease with disease severity and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/26/21
Bentivegna M, Hulme C, Ebell MH | J Am Board Fam Med
Aim: To summarize the best available evidence regarding individual risk factors, simple risk scores, and multivariate models that use patient characteristics, vital signs, comorbidities, and laboratory tests in inpatients.
UPDATED
CLINICAL CHARACTERISTICS
2/26/21
Hurtado-Diaz M, de la Cruz JC, Blanco-Munoz J, et al. | Salud Publica de Mexico
Aim: To summarize and analyze the evidence of the association between Covid-19 and climatic factors. 
CLINICAL CHARACTERISTICS
2/25/21
Zhang H, Ma S, Han T, et al. | Eur J Integr Med
Aim: To review the evidence on the influence of smoking history on the severe and critical outcomes on people with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
2/25/21
McAlpine LS, Fesharaki-Zadeh A, Spusich S | Curr Opin Psychiatry
Aim: To review the outcomes in patients with COVID-19 and NDD.
CLINICAL CHARACTERISTICS
2/25/21
Yin TX, Li Y, Ying Y, et al. | BMC Infect Dis
Aim: To provide systematic evaluation and detailed estimation of prevalence rates of different kinds of common comorbidities in severe and non-severe COVID-19 patients and tries to illustrate the outcomes by combination with underlying pathogenesis to better understand how basic diseases contribute to the aggravation of SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
2/25/21
Ng JJ, Liang ZC, Choong A | J Intensive Care
Aim: To quantitatively synthesize available literature by using meta-analysis of proportions to estimate the weighted average incidence of PTE in critically ill COVID-19 patients admitted to the intensive care unit (ICU).
UPDATED
CLINICAL CHARACTERISTICS
2/24/21
Corona G, Pizzocaro A, Vena W, et al. | Rev Endocr Metab Disord
Aim: To provide an overview and a meta-analysis of main predictors and of country differences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated mortality rate (MR) in hospitalized patients. 
UPDATED
CLINICAL CHARACTERISTICS
2/24/21
Ma S, Xu C, Liu S, et al. | Signal Transduct Target Ther
Aim: To address the efficacy and safety of corticosteroids among severe COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
2/24/21
Widyadharma IPE, Hendellyn A, Dewi A | Egypt J Neurol Psychiatr Neurosurg
Aim: To briefly review neurologic manifestation in COVID-19 infection in the Asia region (South East Asia and the Western Pacific Region).
CLINICAL CHARACTERISTICS
2/24/21
Martins MM, Prata-Barbosa A, da Cunha AJLA | Paediatr Int Child Health
Aim: To review the evidence on clinical presentations, ways of transmission, severity and prognosis of SARS-CoV-2 infection in children and adolescents.
CLINICAL CHARACTERISTICS
2/22/21
Soheili M, Moradi G, Baradaran HR, et al. | J Matern Fetal Neonatal Med
Aim: To find out whether COVID-19 may cause different manifestations and outcomes in the antepartum and postpartum period or not.
CLINICAL CHARACTERISTICS
2/22/21
Koeppen M, Rosenberger P, Magunia H | Clin Med Insights Circ Respir Pulm Med
Aim: To assess the prevalence of cardiovascular comorbidities and complications in ICU-admitted coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
2/22/21
Patel RH, Acharya A, Chand HS, et al. | AIDS Res Hum Retroviruses
Aim: To examine trends of clinical outcomes among patients co-infected with HIV and SARS-CoV-2.
CLINICAL CHARACTERISTICS
2/22/21
Hoste L, Van Paemel R, Haerynck F | Eur J Pediatr
Aim: To perform a systematic review of published cases of this novel multisystem inflammatory syndrome in children associated with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/22/21
Ahmed S, Jafri L, Hoodbhoy Z, et al. | Indian J Crit Care Med
Aim: To review the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.
CLINICAL CHARACTERISTICS
2/22/21
De Sire, A, Andrenelli E, Negrini F, et al. | Eur J Phys Rehabil Med
Aim: To report data of a systematic search performed on papers published in July 2020.
UPDATED
CLINICAL CHARACTERISTICS
2/22/21
Gesesew HA, Koye DN, Fetene DM, et al. | BMJ Open
Aim: To provide a comprehensive evidence on risk factors for transmission, disease severity and COVID-19 related deaths in Africa.
CLINICAL CHARACTERISTICS
2/20/21
Permana H, Huang I, Purwiga A, et al. | Pharmacol Rep
Aim: To address the association between the use of statins and risk of mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/19/21
Zhong Z, Li H, Zhu J, et al. | Medicine
Aim: To summarize the clinical characteristics of patients with severe or critically ill coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
2/19/21
Irfan O, Muttalib F, Tang K, et al. | Arch Dis Child
Aim: To compare paediatric COVID-19 disease characteristics, management and outcomes according to World Bank country income level and disease severity.
UPDATED
CLINICAL CHARACTERISTICS
2/19/21
Taherifard E, Taherifard E, Movahed H, et al. | Hematology
Aim: To systematically review the hematologic autoimmune complications in these patients.
CLINICAL CHARACTERISTICS
2/19/21
Javed A | CNS Neurol Disord Drug Targets
Aim: To assess the associated neurological manifestations with SARS CoV-2 infection.
CLINICAL CHARACTERISTICS
2/19/21
Creta M, Sagnelli C, Celentano G, et al. | J Med Virol
Aim: To highlight currently available literature data on the involvement of the urinary and male genital systems in SARS-SoV-2 infection.
CLINICAL CHARACTERISTICS
2/18/21
Shi L, Xu J, Xiao W, et al. | Ann Allergy Asthma Immunol
Aim: To explore the prevalence of asthma in COVID-19 patients and the relationship between asthma and COVID-19 patients with poor outcomes would be of paramount importance.
CLINICAL CHARACTERISTICS
2/18/21
Xu C, Yi Z, Cai R, et al. | Autoimmun Rev
Aim: To summarize the published and preprint literature that described the clinical characteristics and outcomes of COVID-19 patients with rheumatic diseases, and to provide a higher level of evidence for better clinical decision making.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Henrina J, Putra ICS, Lawrensia S, et al. | Proj Pediatr Cardiol
Aim: To investigate cardiac manifestations, treatment characteristics, and outcomes of paediatric inflammatory multisystem syndrome (PIMS) temporally associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (PIMS-TS).
CLINICAL CHARACTERISTICS
2/17/21
Roshdy A, Zaher S, Fayed H, et al. | Front Cardiovasc Med
Aim: To report the cardiac tissue autopsy findings in coronavirus disease 2019 (COVID-19) decedents.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Maslennikov R, Poluektova E, Ivashkin V, et al. | Infect Dis
Aim: To provide a detailed systematic review of diarrhoea in adults with COVID-19.
CLINICAL CHARACTERISTICS
2/17/21
Atmosudigdo I, Pranata R, Anthonius M, et al.  | J Clin Exp Hepatol
Aim: To evaluate whether dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate whether other comorbidities influence the association.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Gao Y, Chen Y, Liu M, et al. | Epidemiol Infect
Aim: To clarify the association between nervous system diseases and severity or mortality in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Mohamed MFH, A-Shokri S, Yousaf Z, et al. | Front Cardiovasc Med
Aim: To systematically review the literature and explore the pooled prevalence of VTE, PE, and DVT in critically ill COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Chaudhary R, Garg J, Houghton DE, et al. | Mayo Clin Proc Innov Qual Outcomes
Aim: To evaluate differences in thrombo-inflammatory biomarkers between patients with severe COVID-19 infection/death and mild infection.
CLINICAL CHARACTERISTICS
2/17/21
Jenner WJ, Kanji R, Mirsadraee S, et al. | J Thromb Thrombolysis
Aim: To identify the rate of thrombotic complications in ICU-treated patients with COVID-19, to inform recommendations for diagnosis and management.
CLINICAL CHARACTERISTICS
2/16/21
Chang R, Elhusseiny KM, Yeh Y, et al. | PLoS One
Aim: To review the evidence on COVID-19 intensive care unit (ICU) patient characteristics, rates and risks of invasive mechanical ventilation (IMV) and associated outcomes.
UPDATED
CLINICAL CHARACTERISTICS
2/16/21
Wang J, Zhong Z, Mo Y, et al. | Eur Rev Med Pharmacol Sci
Aim: To determine the incidence of the clinical manifestations of COVID-19 in children.
UPDATED
CLINICAL CHARACTERISTICS
2/16/21
Zinellu A, Mangoini AA | Front Med
Aim: To review the available evidence on the clinical implications of this protein specifically in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/12/21
Ng WH, Tipih T, Makoah NA, et al. | mBio
Aim: To evaluate the correlation between comorbidities and their role in the exacerbation of disease in COVID-19 patients leading to fatal outcomes. 
CLINICAL CHARACTERISTICS
2/11/21
Tur-Kaspa I, Tur-Kaspa T, Hildebrand G, et al. | F S Rev
Aim: To determine if COVID-19 is an STD or not, and to clarify its possible effect on fertility.
CLINICAL CHARACTERISTICS
2/11/21
Yan W, Chen D, Bigambo FM, et al. | BMC Infect Dis
Aim: To determine differences in blood cells, lymphocyte subsets, and cytokines in COVID-19 patients with different clinical stages.
CLINICAL CHARACTERISTICS
2/11/21
Vergara-Merino L, Meza N, Couve-Perez C, et al. | Acta Obstet Gynecol Scand
Aim: To conduct a comprehensive analysis of the current evidence on prognosis of COVID-19 in pregnant women.
CLINICAL CHARACTERISTICS
2/11/21
Jin Y, Trope GE, El-Defrawy S, et al. | Eur J Ophthalmol
Aim: To summarize COVID-19 research endeavors by ophthalmologists/researchers in terms of publication numbers, journals and author countries, and to detail key findings.
CLINICAL CHARACTERISTICS
2/11/21
Bavishi C, Whelton PK, Mancia G, et al. | J Hypertens
Aim: To evaluate the association of angiotensin-converting-enzyme inhibitors (ACEI) or AT1 blockers (ARB) therapy with clinical outcomes in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
2/10/21
Syangtan G, Bista S, Dawadi P, et al. | Front Public Health
Aim: To review the evidence on the frequency of asymptomatic individuals and estimated occurrence by age group and gender.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Jayant K, Reccia I, Virdis F, et al. | Clin Transplant
Aim: To determine the pooled prevalence of outcomes among hospitalized LTx recipients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Dhar SK, Vishnupriayn K, Damodar S, et al. | Heliyon
Aim: To establish association between induced cytokines and COVID-19 disease severity to help in prognosis and clinical care.
CLINICAL CHARACTERISTICS
2/10/21
Marafini I, Troncone E, Rocchetti I, et al. | Front Pharmacol
Aim: To determine the risk of RTIs with vedolizumab in patients with IBD.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Kumar J, Meena J, Yadav A, et al.  | J Matern Fetal Neonatal Med
Aim: To synthesize the current evidence for the presence of SARS-CoV-2 RNA in the human milk of mothers with confirmed COVID-19 and its potential role in neonatal SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Umnuaypornlert A, Kanchanasurakit S, Lucero-Prisno DE, et al. | Tob Induc Dis
Aim: To determine the association between smoking and disease severity in COVID-19 infected patients.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, et al. | Front Oncol
Aim: To understand the survival and associated complications in pediatric cancer patients as well as their hospitalization, intensive care, and ventilation care (supplemental oxygen/endotracheal intubation) needs.
CLINICAL CHARACTERISTICS
2/10/21
Nassar M, Nso N, Baraka B, et al. | Diabetes Metab Syndr
Aim: To summarize the prevalence, clinical findings, and outcomes of COVID-19 in patients with T1DM, based on the findings of available evidence.
CLINICAL CHARACTERISTICS
2/8/21
Sunjaya AP, Allida SM, Di Tanna GL, et al. | J Asthma
Aim: To summarise evidence on the risk of infection, severe illness and death from COVID-19 in people with asthma.
CLINICAL CHARACTERISTICS
2/8/21
Laurentius A, Mendel B, Prakoso R | Egypt Heart J
Aim: To show clinical outcome of renin-angiotensin-aldosterone system blockers in hospital treatment of hypertensive patients with coronavirus disease 2019
CLINICAL CHARACTERISTICS
2/8/21
Li P, Li L, Wang S, et al. | Cancer Med
Aim: To systematically review the present evidence on the relationship between antitumor therapy and the clinical outcomes of COVID?19 and to analyze and summarize the available studies in this meta?analysis.
CLINICAL CHARACTERISTICS
2/8/21
Servante J, Swallow G, Thornton JG, et al. | BMC Pregnancy Childbirth
Aim: To determine the rate of arterial or venous thrombosis in pregnant women with confirmed or suspected COVID-19 and to estimate the rate of acquired coagulopathy in pregnant women with confirmed or suspected COVID-19.
CLINICAL CHARACTERISTICS
2/8/21
Mir T, Sattar Y, Ahmad J, et al. | Catheter Cardiovasc Interv
Aim: To meta?analyze studies that examined in?hospital cardiac arrest in COVID patients.
CLINICAL CHARACTERISTICS
2/5/21
Beyrouti R, Best JG, Chandratheva A, et al. | J Neurol
Aim: To describe the characteristics of spontaneous symptomatic intracerebral haemorrhage (ICH) associated with COVID-19.
CLINICAL CHARACTERISTICS
2/5/21
Xu Z, Tang Y, Huang Q, et al. | BMC Nephrol
Aim: To evaluate the incidence of AKI in hospitalized COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
2/4/21
Belsky JA, Tullius BP, Lamb MG, et al. | J Infect
Aim: To define clinical features, laboratory testing, therapeutic interventions and outcomes in immunocompromised patients and then compared these results to the general population with COVID-19.
CLINICAL CHARACTERISTICS
2/4/21
Elshazli RM, Kline A, Elgaml A, et al. | J Med Virol
Aim: To identify COVID-19 patients presenting with gastrointestinal (GI) symptoms during the first and second pandemic waves and investigate their association with the disease outcomes.
CLINICAL CHARACTERISTICS
2/4/21
Li G, Yang Y, Gao D, et al. | Int J Med Sci
Aim: To comprehensively explore the prevalence of transaminase elevation and liver injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/4/21
Alamer AA, Almulhim AS, Alrashed AA, et al. | Healthcare
Aim: To estimate the pooled risks of mortality and disease severity associated with ACEI/ARB use during the first wave of the pandemic.
CLINICAL CHARACTERISTICS
2/3/21
Naeini MB, Sahebi M, Nikbakht F, et al. | Obes Med
Aim: To quantify meta-analytic findings on the association of cardiovascular disease (CVD) comorbidities and COVID-19 severity.
CLINICAL CHARACTERISTICS
2/3/21
Hatmi ZN | SN Compr Clin Med
Aim: To conduct a systematic review of published systematic reviews to provide comprehensive updated information on COVID-19.
CLINICAL CHARACTERISTICS
2/3/21
He X, Cheng X, Feng X, et al. | Front Public Health
Aim: To review the clinical symptoms of the COVID-19 epidemic systematically.
CLINICAL CHARACTERISTICS
2/3/21
Castaneda CA, Castillo M, Rojas JL, et al. | Rev Peru Med Exp Salud Publica
Aim: To describe the risk of infection and developing severe COVID-19 in cancer patients.
UPDATED
CLINICAL CHARACTERISTICS
2/3/21
Scooppettuolo P, Borrelli S, Naeije G | Brain Behav Immun Health
Aim: To provide a clinical approach of SARS-CoV-2 neurological complications based on the direct or indirect (systemic/immune-mediated) role of the SARS-CoV-2 in their genesis.
CLINICAL CHARACTERISTICS
2/3/21
Nasiri N, Sharifi H, Bazrafshan A, et al. | J Ophthalmic Vis Res
Aim: To investigate the prevalence of ocular manifestations in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/3/21
Cevik M, Tate M, Lloyd O, et al. | Lancet Microbe
Aim: To characterise the viral load dynamics of SARS-CoV-2, duration of viral RNA shedding by RT-PCR, and viable virus shedding in various body fluids, and to compare SARS-CoV-2 viral dynamics with those of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Xiang G, Li X, Chen Z, et al. | Ann Palliat Med
Aim: To systematically review the clinical risk factors for fatal outcome of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Li H, Zhao Y, Zhou L, et al. | Dermatol Ther
Aim: To present heterogeneous cutaneous, histopathological manifestations in COVID?19 patients, to investigate the possible relationship between cutaneous manifestations and histopathological features in COVID?19 infection.
CLINICAL CHARACTERISTICS
2/1/21
Pijls BG, Jolani S, Atherley A, et al. | BMJ Open
Aim: To describe the associations of age and sex with the risk of COVID-19 in different severity stages ranging from infection to death.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Ghimire S, Sharma S, Patel A, et al. | SN Compr Clin Med
Aim: To provide a more comprehensive and generalizable understanding of the GI manifestations, and its association with severity in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/1/21
Yisak H, Ewunetei A, Kefale B, et al. | Risk Manag Healthc Policy
Aim: To summarize and decide if there were a link between vitamin D status and COVID-19 infection and prognosis.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Sood M, Sharma S, Sood I, et al. | SN Compr Clin Med
Aim: To analyse the clinical features, proposed pathogenesis and current treatment options for effective management of children with this novel entity.
CLINICAL CHARACTERISTICS
2/1/21
Diaz LA, Idalsoaga F, Cannistra M, et al. | World J Gastroenterol
Aim: To characterize hepatic pathological findings in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Wibowo A, Pranata R, Astuti A, et al. | J Intensive Care
Aim: To assess whether ventricular longitudinal strain can be used as a prognostication tool in patients with coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Yang J, Zheng Y, Gou X, et al. | Int J Infect Dis
Aim: To assess the prevalence of comorbidities in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and the risk of underlying diseases in severe patients compared to non-severe patients.
CLINICAL CHARACTERISTICS
2/1/21
Merola E, Armelao F, de Pretis G | Acta Gastroenterol Belg
Aim: To assess the frequency of gastrointestinal (GI) involvement in COVID-19.
CLINICAL CHARACTERISTICS
2/1/21
Martha JW, Wibowo A, Pranata R | Postgrad Med J
Aim: To evaluate the prognostic performance of elevated lactate dehydrogenase (LDH) in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Lee HW, Yoon C, Jang EJ, et al. | Thorax
Aim: To investigate if ACEI/ARB use is associated with the risk of mortality and severe disease in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Zhang T, Huang W, Guan W, et al. | J Thorac Dis
Aim: To review the evidence on the clinical characteristics between severe and non-severe pateints in the outbreak of COVID-19.
CLINICAL CHARACTERISTICS
2/1/21
Uaprasert N, Moonla C, Sosothikul D, et al. | Clin Appl Thromb Hermost
Aim: To estimate the burden of systemic coagulation activation in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/1/21
Chen C, Zhu C, Yan D, et al. | Int J Infect Dis
Aim: To summarize the epidemiological and radiographical characteristics of asymptomatic infections with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Peravali M, Joshi I, Ahn J, et al. | JTO Clin Res Rep
Aim: To outline patient characteristics, challenges in diagnosis and treatment, and outcomes of lung cancer patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Goel H, Gupta I, Mourya M, et al. | Obstet Gynecol Sci
Aim: To review the evidence on the clinical and laboratory parameters of COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Tleyjeh IM, Bin Abdulhak AA, Tlayjeh H, et al. | Am J Ther
Aim: To perform a meta-analysis of the association between prior use of ACEIs and ARBs and the risk of SARS-CoV-2 infection or hospitalization due to COVID-19 disease.
CLINICAL CHARACTERISTICS
1/29/21
Langford BJ, So M, Raybardhan S, et al. | Clin Microbiol Infect
Aim: To estimate the prevalence and associated factors of antibiotic prescribing in patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Lee JJ, Montazerin SM, Jamil A, et al. | J Med Virol
Aim: To review and synthesize the current evidence on the association of RDW levels with COVID?19 mortality and severity.
UPDATED
CLINICAL CHARACTERISTICS
1/29/21
Mendes NF, Jara CP, Mansour E, et al. | Allergy Asthma Clin Immunol
Aim: To conduct a systematic review of the diagnosis of asthma as a premorbid condition in patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Silverio A, Di Maio M, Citro R, et al. | BMC Cardiovasc Disord
Aim: To investigate the relationship between cardiovascular risk factors and in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Baldini T, Asioli GM, Romoli M, et al. | Eur J Neurol
Aim: To systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) in association with coronavirus disease-2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
1/29/21
Jafari M, Pormohammad A, Sheikh Neshin SA, et al. | Rev Med Virol
Aim: To provide comprehensive data regarding pregnant patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/29/21
Huang C, Soleimani J, Herasevich S, et al. | Mayo Clin Proc
Aim: To synthesize the current and emerging literature describing the clinical features, treatment, outcomes, and risk factors associated with poor prognosis among critically ill patients with COVID-19 during the early months of the pandemic. To provide frontline clinicians with insights for the effective management of severely ill patients with COVID-19. To identify knowledge gaps to guide future research endeavors.
CLINICAL CHARACTERISTICS
1/29/21
Singh AK, Jena A, Kumar-M P, et al. | Intest Res
Aim: To review the evidence on the various clinical manifestations of SARS-CoV-2 in patients with IBD, and to estimate the pooled prevalence of different clinical manifestations.
CLINICAL CHARACTERISTICS
1/29/21
Gholami M, Fawad I, Shadan S, et al. | Int J Infect Dis
Aim: To describe the clinical outcomes and risk factors for SARS- CoV-2 infection in HCW.
CLINICAL CHARACTERISTICS
1/29/21
Yasuhara J, Watanabe K, Takagi H, et al. | Pediatr Pulmonol
Aim: To investigate the epidemiology and clinical course of MIS-C.
CLINICAL CHARACTERISTICS
1/29/21
Parkinson N, Rodgers N, Head Fourman M, et al. | Sci Rep
Aim: To systematically identify and combine existing data from human betacoronavirus research to generate a comprehensive ranked list of host genes involved in COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Xue Y, Sun S, Cai J, et al. | J Renin Angiotensin Aldosterone Syst
Aim: To conduct a meta-analysis on the effects of ACEI/ARB on disease symptoms and laboratory tests in hypertensive patients infected with COVID-19 virus and those who did not use ACEI/ARB.
CLINICAL CHARACTERISTICS
1/29/21
Yao MQ, Zheng QX, Xu J, et al. | Journal of Zhejiang University-SCIENCE B
Aim: To summarize data on demographic characteristics, clinical features, and laboratory findings in non-recurrence and recurrence groups as well as to explore critical factors associated with COVID-19 recurrence.
CLINICAL CHARACTERISTICS
1/29/21
Barek MA, Aziz MA, Islam MS | Heliyon
Aim: To evaluate the impact of age, sex, comorbidities, and clinical characteristics on the severity of COVID-19 to help diagnose and evaluate the current outbreak in clinical decision-making.
CLINICAL CHARACTERISTICS
1/29/21
Kitano T, Kitano M, Krueger C, et al. | PLoS One
Aim: To better understand the global epidemiology of COVID-19 in children and differences in outcome across countries.
UPDATED
CLINICAL CHARACTERISTICS
1/28/21
Yang J, Ma Z, Lei Y | Epidemiol Infect
Aim: To re-evaluate the relationship between obesity and coronavirus-2019 (COVID-19).
CLINICAL CHARACTERISTICS
1/28/21
Piri SM, Edalatfar M, Shool S, et al. | Infect Dis
Aim: To evaluate rate of SARS-CoV-2 recurrence, changes in disease severity, the interval between negative RT-PCR test for SARS-CoV-2 and disease recurrence, disease and patients’ characteristics, risk factors for predicting recurrence and outcomes, as well as the prognosis of recurrent patients.
CLINICAL CHARACTERISTICS
1/28/21
Bhattacharjee S, Banerjee M, Pal R | Postgraduate Medical J
Aim: To summarise the available literature and provide a pooled analysis of the effect of A/AB (without anti-A antibodies) on clinical outcomes in COVID-19 patients compared with B/O (with anti-A antibodies) blood groups.
CLINICAL CHARACTERISTICS
1/28/21
Paliogiannis P, Mangoni AA, Cangemi M, et al. | Clin Exp Med
Aim: To investigate the associations between serum albumin concentrations and COVID-19 disease severity and adverse outcomes.
CLINICAL CHARACTERISTICS
1/27/21
Hussein MH, Elshazli RM, Attia AS, et al. | J Asthma
Aim: To compare asthmatic and non-asthmatic patients to determine the clinical significance of pre-existing asthma in COVID-19 patients. 
CLINICAL CHARACTERISTICS
1/27/21
Xie J, Wang Q, Xu Y, et al. | Ann Palliat Med
Aim: To summarize the characteristics of COVID-19 patients in the early stage of the pandemic and explore the risk factors of disease progression.
CLINICAL CHARACTERISTICS
1/27/21
Hoogenes B, Queree M, Townson A, et al.  | J Neurotrauma
Aim: To provide an overview of the clinical presentation, course, and outcomes of COVID-19 in persons with SCI and identify risk factors for severe disease- and COVID-19-related mortality.
UPDATED
CLINICAL CHARACTERISTICS
1/27/21
Hariyanto TI, Putri C, Frinka P, et al. | AIDS Res Hum Retroviruses
Aim: To analyze the relationship between HIV and poor outcomes of COVID-19 infection.
CLINICAL CHARACTERISTICS
1/26/21
Hartmann J, Ergang A, Mason D, et al. | Diagnostics
Aim: To review the evidence on thromboelastography for management of patients with COVID-19.
CLINICAL CHARACTERISTICS
1/22/21
Shams S, Rathore SS, Anvekar P, et al. | Dermatol Ther
Aim: To summarize clinical features, histopathological hallmarks, and possible pathology behind the maculopapular skin eruptions occurring in Covid-19 patients.
CLINICAL CHARACTERISTICS
1/22/21
Pajo AT, Espiritu AI, Apor ADAO, et al. | Neurol Sci
Aim: To review the currently available neuropathological data on COVID-19 including post-mortem findings of patients following a death from COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
1/22/21
Lim AYH, GOH JL, Chua MCW, et al. | BMC Pulm Med
Aim: To assess the temporal progression of blood and radiology findings of patients with COVID-19.
CLINICAL CHARACTERISTICS
1/22/21
Oran DP, Topol EJ | Ann Intern Med
Aim: To estimate the proportion of persons infected with SARS-CoV-2 who never develop symptoms.
CLINICAL CHARACTERISTICS
1/20/21
Mameli S, Marcialis MA, Bassareo PP, et al. | Panmiverva Medica
Aim: To review the evidence on the features of liver involvement and damage in the course of COVID-19.
CLINICAL CHARACTERISTICS
1/19/21
Meng J, Ma Y, Jia J, et al. | Front Immunol
Aim: To compare the similarities and differences focusing on ferritin and cytokine levels between severe COVID-19 and active AOSD. 
CLINICAL CHARACTERISTICS
1/19/21
Kim J, Han SC, Jo HD, et al. | J Korean Med Sci
Aim: To investigate the factors that contribute to the inter-study variability in the prevalence of olfactory and gustatory dysfunction.
CLINICAL CHARACTERISTICS
1/19/21
Cunarro-Lopez Y, Pintado-Recarte P, Cueto-Hernandez I, et al. | J Clin Med
Aim: To describe and analyze the profile of the obstetric patients according to the country of origin of the publication.
UPDATED
CLINICAL CHARACTERISTICS
1/18/21
McClatchey K, Jackson T, Delaney B, et al. | J Allergy Clin Immunol Pract
Aim: To explore whether the information addresses relevant health actions to minimize the risk of contracting and spreading COVID-19, and encourages asthma self-management.
CLINICAL CHARACTERISTICS
1/18/21
Zeng W, Qi K, Ye M, et al. | Eur J Gastroenterol Hepatol
Aim: To explore the relationship between gastrointestinal symptoms and the severity of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/18/21
Martha JW, Wibowo A, Pranata R | Diabetes Metab Syndr
Aim: To evaluate the prognostic performance of hypocalcemia in patients with coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
1/15/21
Shareef MA, Bashaiwth HM, AlAkbari AO, et al. | Avicenna J Med
Aim: To review the evidence on SARS-CoV-2 and HIV coinfection.
CLINICAL CHARACTERISTICS
1/15/21
Mohamadi M, Goodarzi A, Aryannejad A, et al. | Med J Islam Repub Iran
Aim: To review the evidence on SARS-CoV-2 infection complications in elderly individuals.
CLINICAL CHARACTERISTICS
1/15/21
Cirillo N, Bizzoca ME, Lo Muzio E, et al. | Acta Odontol Scand
Aim: To collect comprehensive data on the taste alterations prevalence worldwide and, precisely, in 16 countries.
CLINICAL CHARACTERISTICS
1/14/21
Zinellu A, Mangoini AA | J Clin Med
Aim: To review the evidence on the predictive role of the red blood cell distribution width (RDW), a routine hematological test, in patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/13/21
Hassanipour S, Faradonbeh SB, Momeni K, et al. | Int J Reprod Biomed
Aim: To investigate the clinical manifestation include signs and symptoms, laboratory results, and perinatal outcomes in pregnant women with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/13/21
Oshay RR, Chen MYC, Fields BKK, et al. | Clin Imaging
Aim: To conduct a comprehensive systematic review of all existing literature regarding imaging findings on chest CT and associated clinical features in pregnant patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
1/12/21
Soltani S, Tabibzadeh A, Zakeri A, et al. | Rev Neurosci
Aim: To systematically review the COVID-19 associated central nervous system manifestations, mental and neurological symptoms.
CLINICAL CHARACTERISTICS
1/11/21
Israfil SMH, Sarker MMR, Rashid PT, et al. | Front Public Health
Aim: To summarize the global clinical characteristics of the COVID-19 patients systematically and identify their diagnostic challenges to help the medical practitioners properly diagnose and for better management of COVID-19 patients. 
CLINICAL CHARACTERISTICS
1/11/21
Hariyanto TI, Japar KV, Kwenandar F, et al. | Am J Emerg Med
Aim: To evaluate the difference between these parameters in severe and nonsevere disease and to provide the optimal cutoff value for predicting severe disease.
CLINICAL CHARACTERISTICS
1/11/21
Zhao X, Gang X, He G, et al. | Front Endocrinol
Aim: To compare the impacts of obesity on the severity and mortality of influenza and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/10/21
Lewis A, Frontera J, Placantonakis DG, et al. | J Neurol Sci
Aim: To review the literature on cerebrospinal fluid (CSF) testing in patients with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2.
CLINICAL CHARACTERISTICS
1/9/21
Mansourian M, Ghandi Y, Habibi D, et al. | Arch Pediatrie
Aim: To provide a meta-analysis of previously published papers on the COVID-19-related clinical features and laboratory findings in children.
CLINICAL CHARACTERISTICS
1/8/21
Aminian A, Tu C, et al. | Obes Surg
Aim: To measure the association between history of bariatric surgery and the severity of COVID-19.
CLINICAL CHARACTERISTICS
1/6/21
Islam MM, Poly TN, Walther BA, et al. | Front Med
Aim: To assess clinical manifestations and neonatal outcomes of pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
1/6/21
Badawi A, Vasileva D | World J Clin Cases
Aim: To analyze and compare the profile of COVID-19 cases between China and North America as two regions that differ in many environmental, host and healthcare factors related to disease risk.
CLINICAL CHARACTERISTICS
1/6/21
Santos REA, da Silva MG, do Monte Silva MCB, et al. | Am J Otolaryngol
Aim: To conduct a systematic review of the literature to investigate the time of onset and duration of symptoms of loss of smell and taste in patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
1/5/21
Benito DA, Bestourous DE, Tong JY, et al. | Otolaryngol Head Neck Surg
Aim: To determine the cumulative incidences of decannulation and mechanical ventilation weaning in patients with coronavirus disease 2019 (COVID-19) who have undergone a tracheotomy. 
CLINICAL CHARACTERISTICS
1/5/21
Hashemi-madani N, Emami Z, Janani L, et al. | Clin Imaging
Aim: To assess the relationship between different chest CT features and severity of clinical presentation in COVID-19.
CLINICAL CHARACTERISTICS
1/4/21
Post N, Eddy D, Huntley C, et al. | PLoS One
Aim: To comprehensively evaluate the evidence describing the antibody response to SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
1/4/21
Khamis AH, Jaber M, Azar A, et al. | J Formos Med Assoc
Aim: To systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes.
UPDATED
CLINICAL CHARACTERISTICS
1/4/21
Desai A, Gupta R, Advani S, et al. | Cancer
Aim: To assess the overall mortality in this population through a meta?analysis of published data on COVID?19 and cancer.
UPDATED
CLINICAL CHARACTERISTICS
1/4/21
Fu L, Liu X, Su Y, et al. | Clin Cardiol
Aim: To investigate prevalence of cardiac injury and its impact on the outcomes in patients with COVID?19.
CLINICAL CHARACTERISTICS
1/4/21
Del Zompo F, De Siena M, Ianiro G, et al. | Eur Rev Med Pharmacol Sci
Aim: To systematically review the prevalence of liver involvement in patients with SARS-CoV-2 infection at their hospital admission, and its correlation with disease severity and clinical outcomes in patients with or without pre-existing chronic liver disease.
CLINICAL CHARACTERISTICS
1/4/21
Liu H, Yang D, Chen X, et al.  | Cancer Med
Aim: To qualify the potential effects of anticancer therapies on the clinical outcomes, such as mortality, admission to the intensive care unit (ICU), and the severity of COVID?19, in patients with cancer infected with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
1/3/21
Cai R, Zhang J, Zhu Y, et al. | Int Urol Nephrol
Aim: To conduct a literature review and meta-analysis to understand the frequency of mortality among CKD patients infected with COVID-19.
CLINICAL CHARACTERISTICS
1/2/21
Liu N, Sun J, Wang X, et al. | Int J Infect Dis
Aim: To assess the association between low vitamin D status and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/31/20
Chowdhary A, Subedi R, Tandon M | Brain Sci
Aim: To collect, analyze, and summarize the neurological findings in the MRI among patients with COVID-19
CLINICAL CHARACTERISTICS
12/31/20
Tian T, Huo X | J Infect Dev Ctries
Aim: To review the evidence on the secondary attack rate of SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/30/20
Mehraeen E, Alinaghi SAS, Nowroozi A, et al. | Indian Heart J
Aim: To pinpoint different observed ECG findings and discuss their clinical significance.
CLINICAL CHARACTERISTICS
12/30/20
Lai X, Liu J, Zhang T, et al. | BMJ Open
Aim: To systematically assess the clinical, laboratory and imaging predictors as well as prediction models for severe or critical illness and mortality in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/30/20
Dorrell R, Dourgherty MK, Barash EL, et al. | JGH Open
Aim: To characterize the prevalence of gastrointestinal (GI) and hepatic involvement in COVID?19 and specifically assess the prevalence of GI symptoms in isolation.
UPDATED
CLINICAL CHARACTERISTICS
12/30/20
Mondal R, Ganguly U, Deb S, et al. | J Neurovirol
Aim: To summarise the clinical profile, investigations and radiological findings among patients with SARS-CoV-2 associated meningoencephalitis.
UPDATED
CLINICAL CHARACTERISTICS
12/30/20
Brown WA, Moore EM, Watters DA | ANZ J Surg
Aim: To estimate the effect size of coronavirus disease 2019 (COVID-19) on post-operative mortality.
CLINICAL CHARACTERISTICS
12/30/20
Maharaj S, Alvarez MB, Mungul S, et al. | Laryngoscope Investig Otolaryngol
Aim: To describe otologic dysfunction in patients with the novel SARS?CoV?2.
CLINICAL CHARACTERISTICS
12/30/20
SeyedAlinaghi S, Oliaei S, Kianzad S, et al. | World J Virol
Aim: To summarize the recent findings and reports of COVID-19 reinfection in patients previously reCoVered from the disease.
CLINICAL CHARACTERISTICS
12/30/20
Parsay S, Vosoughi A, Khabbaz A, et al. | J Stroke Cerebrovasc Dis
Aim: To investigate the incidence of ischemic CVA and the mortality due to it in the setting of COVID-19.
CLINICAL CHARACTERISTICS
12/28/20
Pranata R, Henrina J, Lim MA, et al. | Arch Gerontol Geriatr
Aim: To quantify the dose-response relationship between CFS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/28/20
Hassani NS, Shojaee A, Khodaprast Z, et al. | J Intensive Care Med
Aim: To investigate the echocardiographic features of cardiac injury related to COVID-19 and their prognostic value.
CLINICAL CHARACTERISTICS
12/28/20
Aziz M, Goyal H, Haghbin H, et al. | Am J Med Sci
Aim: To evaluate the prevalence of “loss of smell” in COVID-19 as well as its utility for prognosticating the disease severity.
CLINICAL CHARACTERISTICS
12/28/20
Clement ND, Ng N, Simpson CJ, et al. | Bone Joint Res
Aim: To assess: 1) the prevalence of COVID-19 in hip fracture patients during the first wave of the pandemic; 2) the associated rate and risk of mortality compared to those without COVID-19; 3) the demographics associated with COVID-19-positive patients; 4) the time from the day of admission to diagnosis of COVID-19; and 5) length of follow-up after a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
12/23/20
Bhuiyan MU, Stiboy E, Hassan MZ, et al. | Vaccine
Aim: To review the evidence on the epidemiological and clinical characteristics of COVID-19 infection in children under five years.
UPDATED
CLINICAL CHARACTERISTICS
12/23/20
Scheen AJ | Diabetes Metab
Aim: To investigate the impact of previous statin therapy in patients hospitalized for COVID-19.
CLINICAL CHARACTERISTICS
12/22/20
Neef V, Buxmann H, Rabenau HF, et al. | Pediatr Neonatal
Aim: To characterize a large number of neonates delivered by rRT-PCR confirmed SARS-CoV-2 positive mothers.
CLINICAL CHARACTERISTICS
12/22/20
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
12/22/20
Rocha APD, Atallah ÁN, Pinto ACPN, et al. | Sao Paulo Med J
Aim: To assess whether patients undergoing pharmacological treatment for IMID present higher risk of worse outcomes when diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
12/22/20
Rattka M, Dreyhaupt J, Winsauer C, et al. | Heart
Aim: To assess the mortality of patients with STEMI admitted during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Bae S, Kim SR, Kim M, et al.  | Heart
Aim: To estimate the prevalence and risk factors for CVD among patients with COVID-19 in different age groups.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Sarkar S, Khanna P, Singh A | J Med Virol
Aim: To evaluate the consequence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with concurrent co-infections based on the publications reported to date.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Tyrrell CSB, Mytton OT, Gentry SV, et al. | Thorax
Aim: To provide acute insights into the guidance on which patients are treated in ICU and receive ventilation during periods of high demand for ICU capacity during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Mathioudakis AG, Fally M, Hashad R, et al. | Life
Aim: To describe the outcomes evaluated in 415 RCTs on the management of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Rabbani G, Islam SMS, Rahman MA, et al. | Expert Rev Respir Med
Aim: To investigate COVID-19 mortality and severity among patients with pre-existing COPD.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Rodrigues C, Baía I, Domingues R, et al. | Front Public Health
Aim: To review knowledge on the impact of COVID-19 on pregnancy and describe the outcome of published cases of pregnant women diagnosed with COVID-19, as well as the characteristics of COVID-19 positive women who delivered in Portugal by 31 of March 2020. 
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
July J, Pranata R | Geriatr Gerontol Int
Aim: To discover whether age, sex and other comorbidities might affect the association between dementia and mortality.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Islam MA, Alam SS, Kundu S, et al. | Front Neurol
Aim: To conduct a comprehensive systematic review and meta-analysis to estimate the overall pooled prevalence of headache in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Viner RM, Ward J, Hudson L, et al. | Arch Dis Child
Aim: To undertake a systematic review of reviews of the prevalence of symptoms and signs of COVID-19 in those aged under 20 years.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Wang B, Luo Q, Zhang W, et al. | Kidney Blood Press Res
Aim: To evaluate the association of chronic kidney disease (CKD) and acute kidney injury (AKI) with the clinical prognosis of patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
12/17/20
Zafari M, Rad MTS, Mohseni F, et al. | Hemoglobin
Aim: To determine mortality and morbidity of infected ?-thal patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
12/17/20
Wan J, Wang X, Su S, et al. | JGH Open
Aim: To investigate the exact prevalence of digestive symptoms and liver injury in COVID?19 patients and compare the difference between patients with and without digestive symptoms. 
CLINICAL CHARACTERISTICS
12/17/20
Suh YJ, Hong H, Ohana M, et al. | Radiology
Aim: To conduct meta-analysis of the study-level incidence of PE and DVT and to evaluate the diagnostic accuracy of D-dimer tests for PE from multicenter individual patient data. 
CLINICAL CHARACTERISTICS
12/17/20
Silver SA, Beaubien-Souligny W, Shah PS, et al. | Kidney Med
Aim: To determine the pooled prevalence of AKI and KRT among hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
12/16/20
Thakkar S, Arora S, Kumar A, et al. | Clin Med Insights Cardiol
Aim: To provide a foundation for understanding the CV manifestations and outcomes of COVID-19.
CLINICAL CHARACTERISTICS
12/16/20
Lazarus G, Audrey J, Kharisma Wangsaputra V, et al. | Diabetes Res Clin Pract
Aim: To investigate the prognostic value of admission blood glucose (BG) in predicting COVID-19 outcomes, including poor composite outcomes (mortality/severity), mortality, and severity.
CLINICAL CHARACTERISTICS
12/16/20
Liu S, Cao Y, Du T, et al. | J Allergy Clin Immunol Pract
Aim: To investigate the asthma prevalence among COVID-19 patients and compare outcomes between asthma and non-asthma patients.
UPDATED
CLINICAL CHARACTERISTICS
12/16/20
Zhang R, Ni L, Di X, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To identify the prevalence of VTE, PE, and DVT in consecutive hospitalized patients, ICU patients, and non-ICU patients with COVID-19 by a meta-analysis based on currently available clinical studies.
CLINICAL CHARACTERISTICS
12/16/20
Liu N, Zhang T, Ma L, et al. | Blood Rev
Aim: To elucidate the association between ABO blood group and increased COVID-19 morbidity and mortality.
CLINICAL CHARACTERISTICS
12/15/20
Moazzami B, Chaichian S, Kasaeian A, et al. | PLoS One
Aim: To assess the association of metabolic risk factors and risk of Covid-19.
CLINICAL CHARACTERISTICS
12/15/20
Siow I, Lee KS, Zhang JJY, et al. | J Stroke Cerebrovasc Dis
Aim: To evaluate the epidemiology, clinical course, and outcomes of patients who suffer from stroke as a complication of COVID-19.
CLINICAL CHARACTERISTICS
12/14/20
Ojha V, Verma M, Pandey NN, et al.  | J Thorac Imaging
Aim: To assess the important imaging features on CMR in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/14/20
Liao S, Shao S, Cheng C, et al. | Crit Care
Aim: To review the evidence on the incidence and mortality rates after incident arrhythmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/14/20
Novelli L, Motta F, De Santis M, et al. | J Autoimmun
Aim: To evaluate the COVID-19-related autoimmune/rheumatic disorders.
CLINICAL CHARACTERISTICS
12/12/20
Badawi AE, Elsheikh SS, Addeen SZ, et al. | J Curr Ophthalmol
Aim: To discuss the ocular manifestations provoked by novel coronavirus 2019 (COVID-19) disease in humans, the natural history of the disease in the eye, and its treatment.
CLINICAL CHARACTERISTICS
12/9/20
Sriwastava S, Kataria S, Tandon M, et al. | J Neurol Sci
Aim: To compare and summarize the demographics, clinical features, Brighton criteria, immunological and laboratory findings with a focus on modified Erasmus GBS Outcome Score (mEGOS) in SARS-CoV-2 patients with GBS and its variants.
CLINICAL CHARACTERISTICS
12/8/20
Keshavarz P, Rafiee F, Kavandi H, et al. | Clin Imaging
Aim: To review the clinical and radiologic features of GI ischemia and its related complications in thirty-one COVID-19 patients reported in literature.
CLINICAL CHARACTERISTICS
12/8/20
Badal S, Bajgain KT, Badal S, et al. | J Clin Virol
Aim: To conduct a comprehensive meta-analysis and systematic review to collect and analyze current evidence about COVID-19 in the pediatric population.
CLINICAL CHARACTERISTICS
12/2/20
Loomba RS, Aggarwal G, Villarreal EG, et al. | Blood Coagul Fibrinolysis
Aim: To compare laboratory results in COVID-19 patients with and without DVT with the aim of identifying risk factors for DVT in this population.
CLINICAL CHARACTERISTICS
12/1/20
Yang J, Tian C, Chen Y, et al. | J Med Virol
Aim: To evaluate the impact of obesity on the onset, exacerbation, and mortality of coronavirus disease 2019 (COVID?19); and compare the effects of different degrees of obesity. 
UPDATED
CLINICAL CHARACTERISTICS
11/27/20
Zhang X, Yang X, Jiao H, et al. | Aging
Aim: To investigate the role of coagulation dysfunction in the severity of COVID-19 progression.
CLINICAL CHARACTERISTICS
11/27/20
Asadi-Pooya AA, Simani L, Shahisavandi M, et al. | Neurol Sci
Aim: To discuss the evidence on the occurrence of de novo seizures in patients with COVID-19, the consequences of this catastrophic disease in people with epilepsy (PWE), and the electroencephalographic (EEG) findings in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/27/20
Rostami A, Sepidarkish M, Leeflang MMG, et al. | Clin Microbiol Infect
Aim: To estimate the global and regional seroprevalence rates in humans of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and to assess whether seroprevalence is associated with geographical, climatic and/or sociodemographic factors.
CLINICAL CHARACTERISTICS
11/26/20
Lombardi A, Asahi AM, Gupta A, et al.  | Radiol Med
Aim: To review the most common extra-pulmonary manifestations of SARS, Influenza, MERS, and COVID-19.
CLINICAL CHARACTERISTICS
11/25/20
Vakhshoori M, Heidarpour M, Shafie D, et al. | Arch Iran Med
Aim: To analyze the available COVID-19 data on acute cardiac injury, using troponin and brain natriuretic peptide (BNP) levels.
CLINICAL CHARACTERISTICS
11/25/20
Yang X, Tian S, Guo H | Int Immunopharmacol
Aim: To gain clarity regarding AKI incidence and renal replacement therapy (RRT) use in COVID-19 patients.
CLINICAL CHARACTERISTICS
11/25/20
Chu C, Zeng S, Hasan AA, et al. | Br J Clin Pharmacol
Aim: To review the evidence on the effect of RAAS blockers on the expression of ACE2 and the risk of SARS-Cov-2 infection.
CLINICAL CHARACTERISTICS
11/25/20
Sameni F, Hajikhani B, Yaslianifard S, et al. | Front Med
Aim: To provide a systematic review and meta-analysis of various skin manifestations among patients with COVID-19 through case reports/case series and prevalence studies.
CLINICAL CHARACTERISTICS
11/25/20
Jindal R, Chauhan P | J Family Med Prim Care
Aim: To describe the cutaneous manifestations of COVID-19 patients from diverse regions with the aim of highlighting any important associations.
CLINICAL CHARACTERISTICS
11/25/20
Kiss S, Gede N, Hegyi P, et al. | Med Microbiol Immunol
Aim: To review the evidence on the correlation between early changes in the laboratory parameters and the clinical outcomes of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Wang KC, Xiao R, Cheung ZB, et al. | J Orthop
Aim: To assess the risk of early mortality in hip fracture patients with COVID-19 infection who undergo surgical intervention.
CLINICAL CHARACTERISTICS
11/25/20
Li B, Zhang S, Zhang R, et al. | Front Pediatr
Aim: To evaluate the epidemiological spectrum and clinical characteristics of children infected with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Jiménez D, García-Sanchez A, Rali P, et al. | Chest
Aim: To review the evidence on the incidence of VTE and bleeding among hospitalized patients with COVID-19?
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Saniasiaya J, Islam MA, Abdullah B | Laryngoscope
Aim: To estimate the overall pooled prevalence of olfactory dysfunction in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Singh AK, Jena A, Kumar-M P, et al. | United European Gastroenterol J
Aim: To review the evidence on the risk of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection and clinical outcomes of coronavirus disease (COVID-19) in inflammatory bowel disease.
CLINICAL CHARACTERISTICS
11/25/20
Galanis P, Vraka I, Fragkou D, et al. | J Hosp Infect
Aim: To determine the seroprevalence of SARS-CoV-2 antibodies among HCWs, and to find out the factors that are associated with this seroprevalence.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Katsanos AH, Palaiodimou L, Zand R, et al. | Ann Neurol
Aim: To evaluate the potential impact of coronavirus disease (COVID-19) on the management and outcomes of acute stroke.
CLINICAL CHARACTERISTICS
11/24/20
Chang PC, Yang CC, Kao KC, et al  | Aging
Aim: To compare clinical outcomes in patients hospitalized for COVID-19 with those of patients hospitalized for SARS.
CLINICAL CHARACTERISTICS
11/24/20
Novoa RH, Quintana W, Llancarí P, et al. | Travel Med Infect Dis
Aim: To review all cases from the current literature and provide up-to-date scientific evidence on the clinical characteristics, maternal outcomes, perinatal outcomes and the possibility of vertical transmission in the infected pregnant women.
UPDATED
CLINICAL CHARACTERISTICS
11/23/20
Zhang J, Wang H, Wei M, et al.  | Aging
Aim: To assess the incidence of cerebrovascular disease as a comorbidity in COVID-19 patients.
CLINICAL CHARACTERISTICS
11/20/20
Ji P, Zhu J, Zhong Z, et al. | Medicine
Aim: To review the evidence on the potential association between inflammatory markers and severe COVID-19.
CLINICAL CHARACTERISTICS
11/20/20
Bin Arif T, Khalid S, Siddiqui MS, et al. | Hong Kong Med J
Aim: To provide insight into the incidence, patterns, risk factors, histopathological findings, and relationship with disease severity of COVID-19-associated liver injury.
CLINICAL CHARACTERISTICS
11/20/20
Vijenthira A, Gong IY, Fox TA, et al. | Blood
Aim: To perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for patients with hematologic malignancy infected with COVID-19 .
CLINICAL CHARACTERISTICS
11/20/20
Wang C, Zhang H, Zhou M, et al. | Eur Rev Med Pharmacol Sci
Aim: To explore the relationship between the prognosis of COVID-19 patients and thromboembolic events.
CLINICAL CHARACTERISTICS
11/20/20
Tsankov BK, Allaire JM, Irvine MA, et al  | Int J Infect Dis
Aim: To investigate the effects of pediatric comorbidities on COVID-19 severity. 
CLINICAL CHARACTERISTICS
11/20/20
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, et al. | Bol Med Hosp Infant Mex
Aim: To analyze the available data associated with COVID-19 infection and mortality in pediatric cancer patients and to provide useful information to plan and design strategies in this group.
CLINICAL CHARACTERISTICS
11/19/20
Haque A, Minhaj A, Ahmed A, et al. | AIMS Medical Science
Aim: To analyze the prevalence of thromboembolic events in the hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
11/19/20
Kashour T, Abdulhak AAB, Tlayjeh H, et al. | Am J Ther
Aim: To review the evidence on the association between prior use of ACEIs and ARBs and mortality due to COVID-19 disease.
CLINICAL CHARACTERISTICS
11/19/20
Ouyang L, Gong Y, Zhu Y, et al. | Am J Emerg Med
Aim: To explore the relationship of acute kidney injury (AKI) with the severity and mortality of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
11/19/20
Kubjane M, McCreedy N, Cariou B, et al. | Endocrinol Metab
Aim: To investigate the association between diabetes and COVID-19 disease severity in patients hospitalized due to COVID-19.
CLINICAL CHARACTERISTICS
11/19/20
Cheruiyot I, Kipkorir V, Ngure B, et al. | Am J Emerg Med
Aim: To evaluate whether malignancies are associated with a significantly enhanced odds of COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
11/19/20
Udomsinprasert W, Jittikoon J, Sangroongruangsri S, et al. | J Clin Immunol
Aim: To determine associations of circulating levels of inflammatory cytokines with severity and mortality of COVID-19 by systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
11/19/20
Sze S, Pan D, Nevill CR, et al. | EClinicalMedicine
Aim: To determine whether the risk of SARS-CoV-2 infection, COVID-19 intensive care unit (ICU) admission and mortality are associated with ethnicity. 
UPDATED
CLINICAL CHARACTERISTICS
11/19/20
Meng M, Zhao Q, Kumar R, et al. | Aging
Aim: To review the evidence on the effects of coronary heart disease (CHD), hypertension and diabetes on the development of severe COVID-19. 
CLINICAL CHARACTERISTICS
11/19/20
Yang J, Tian C, Chen Y, et al. | J Med Virol
Aim: To explore the relationship between obesity and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/19/20
Li X, Liu C, Mao Z, et al. | Crit Care
Aim: To evaluate the predictive values of NLR on disease severity and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/19/20
Wu T, Zou Z, Yang D, et al. | Age Aging
Aim: To explore the factors associated with prevalence of venous thromboembolism (VTE) in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/18/20
Abdulla S, Hussain A, Azim D, et al. | Cureus
Aim: To draw generalized conclusions regarding impaired liver biochemistry and its potential relationship with COVID-19 disease severity.
CLINICAL CHARACTERISTICS
11/18/20
Bansal A, Kumar A, Patel D, et al. | Am J Cardiol
Aim: To evaluate the association between cardiac injury and all-cause mortality, intensive care unit (ICU) admission, mechanical ventilation, acute respiratory distress syndrome, acute kidney injury and coagulopathy.
CLINICAL CHARACTERISTICS
11/18/20
Koshy AN, Murphy AC, Farouque O, et al. | Intern Med J
Aim: To investigate whether RAS inhibitors increased the likelihood of a positive test or death/severe illness in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/17/20
Yonas E, Alwi I, Pranata R, et al. | Diabetes Metab Syndr
Aim: To comprehensively study the various levels of immunological parameters in patients with COVID 19.
CLINICAL CHARACTERISTICS
11/16/20
Raharja A, Tamara A, Kok LT | J Racial Ethn Health Disparities
Aim: To review the association between ethnicity and poor Covid-19 outcomes including all-cause mortality, hospitalisation, critical care admission, respiratory and kidney failure.
UPDATED
CLINICAL CHARACTERISTICS
11/16/20
Wong CKH, Wong JYH, Tang EHM, et al. | Sci Rep
Aim: To investigate the comorbidities, symptoms, clinical characteristics and treatment of COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
11/16/20
Kouhsari F, Azizian K, Sholeh M, et al. | Indian J Med Microbiol
Aim: To review data of the novel Coronavirus (2019-nCoV) by analyzing all the published retrospective studies on the clinical, epidemiological, laboratory, and radiological characteristics of patients with 2019-nCoV.
CLINICAL CHARACTERISTICS
11/16/20
Yang Q, Yang X | PLoS One
Aim: To evaluate the association of kidney impairment with the development of COVID-19.
CLINICAL CHARACTERISTICS
11/16/20
Juhasz MF, Ocskay K, Kiss S, et al. | World J Gastroenterol
Aim: To assess all the available evidence in the literature relating to coronavirus disease 2019 (COVID-19) and AP.
UPDATED
CLINICAL CHARACTERISTICS
11/16/20
Akin H, Kurt R, Tufan F, et al. | Diseases
Aim: Too present the currently available data regarding the GI symptoms of COVID-19 patients, and to compare the frequency of GI symptoms in early stage (Eastern) mostly Chinese data to the current stage (Western) non-Chinese data. 
CLINICAL CHARACTERISTICS
11/16/20
Bustos R, Jaramillo-Bustamante JC, Vasquez-Hoyos P, et al. | Pediatr Emerg Care
Aim: To review the evidence on pediatric inflammatory multisystem syndrome associated with SARS-CoV-2.
CLINICAL CHARACTERISTICS
11/16/20
Pinedo-Torres I, Flores-Fernandez M, Yovera-Aldana M, et al. | Clin Med Insights Endocrinol Diabetes
Aim: To determine the prevalence of diabetes comorbidity and its associated unfavorable health outcomes in patients with acute respiratory syndromes for coronavirus disease according to virus types.
UPDATED
CLINICAL CHARACTERISTICS
11/14/20
Zou H, Lu J, Liu J, et al. | Int J Infect Dis
Aim: To collect current evidence on pediatric PMIS and provide insights into pathogenesis, hopefully, providing possible clues for further research and treatment at this moment.
CLINICAL CHARACTERISTICS
11/13/20
Haiduc AA, Ogunjimi M, Shammus R, et al. | Cardiol Young
Aim: To examine the literature to determine if both paediatric and adult patients diagnosed with congenital heart disease (CHD) are at a higher risk of poor outcomes if they have the coronavirus disease 2019 (COVID-19), compared to those without CHD.
CLINICAL CHARACTERISTICS
11/13/20
Kubota T, Kuroda N | Clin Neurol Neurosurg
Aim: To evaluate the severity of COVID-19 and its effect on neurological symptoms in patients with preexisting neurological disorder and COVID-19.
CLINICAL CHARACTERISTICS
11/13/20
Bellos I, Pandita A, Panza R | Eur J Obstet Gynecol Reprod Biol
Aim: To evaluate maternal and neonatal outcomes in covid-19 pregnancies and identify factors associated with perinatal viral transmission.
CLINICAL CHARACTERISTICS
11/13/20
Lin L, Wang X, Ren J, et al. | BMJ Open
Aim: To analyse the incidence, risk factors and impact of acute kidney injury (AKI) on the prognosis of patients with COVID-19.
CLINICAL CHARACTERISTICS
11/12/20
Vardhelli V, Pandita A, Pillai A, et al. | Eur J Pediatr
Aim: To summarize available literature on the clinical spectrum of COVID-19 in neonates and mothers and suggest a practical approach towards management of clinical scenarios.
CLINICAL CHARACTERISTICS
11/12/20
Li P, Wang Y, Peppelenbosch MP, et al. | Int J Infect Dis
Aim: To comprehensively compare the clinical features of hospitalized COVID-19 patients with hospitalized 2009 influenza pandemic patients.
CLINICAL CHARACTERISTICS
11/11/20
Kuswardhani RAT, Henrina J, Pranata R, et al. | Diabetes Metab Syndr
Aim: To assess the association between CCI and a composite of poor outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
11/11/20
Zuin M, Guasti P, Roncon L, et al. | Int J Geriatr Psychiatry
Aim: To evaluate the mortality risk in elderly patients with dementia and COVID?19 infection.
CLINICAL CHARACTERISTICS
11/11/20
Aziz M, Haghbin H, Lee-Smith W, et al. | Ann Gastroenterol
Aim: To review the evidence on the gastrointestinal predictors of severe COVID-19.
CLINICAL CHARACTERISTICS
11/11/20
Choi Y, Lee MK | Eur J Radiol
Aim: To comprehensively evaluate the incidences of abnormal neuroimaging findings in patients with COVID-19 via a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
11/11/20
Mudatsir M, Fajar JK, Wulandari L, et al. | F1000
Aim: To identify the predictors associated with poor clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/9/20
Alimohamadi Y, Sepandi M, Taghdir M, et al.  | J Prev Med Hyg
Aim: To estimate the prevalence of clinical symptoms of COVID-19 in a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
11/9/20
Ye L, Yang Z, Liu J, et al. | J Gastroenterol Hepatol
Aim: To highlight the gaps in our knowledge about the prevalence and clinical significance of GI symptoms in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/9/20
Aggarwal K, Agarwall A, Jaiswal N, et al.  | PLoS ONE
Aim: To evaluate the epidemiology and clinical features of ocular surface manifestations and complications related to COVID-19 infection, to assess the risk of transmission to patients and healthcare workers through ocular secretions and to determine whether ocular involvement has any correlation with the severity of respiratory symptoms and overall prognosis.
UPDATED
CLINICAL CHARACTERISTICS
11/9/20
Hasan I, Rashid T, Suliman S, et al. | Rom J Intern Med
Aim: To review the evidence on COVID-19 in kidney transplant recipients.
CLINICAL CHARACTERISTICS
11/9/20
Ssentongo A, Ssentongo P, Heilbrunn E, et al | Open Heart
Aim: To explore the association of RAAS inhibitors, including angiotensin-converting inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) with COVID-19 mortality in patients with hypertension. 
UPDATED
CLINICAL CHARACTERISTICS
11/9/20
Matsushita K, Ding N, Kou M, et al. | Glob Heart
Aim: To explore pre-existing CVD and its traditional risk factors as risk factors of severe COVID-19 (defined as death, acute respiratory distress syndrome, mechanical ventilation, or intensive care unit admission). 
UPDATED
CLINICAL CHARACTERISTICS
11/9/20
Sridharan GK,  Vegunta R, Rokkam VRP, et al. | Am J Ther
Aim: To examine and appraise the incidence of VTE, major VTE, PE, and DVT in hospitalized COVID-19 patients by meta-analysis methods and, in particular, analyze whether the use of therapeutic anticoagulation decreased the odds of thromboembolic events compared with prophylactic anticoagulation.
CLINICAL CHARACTERISTICS
11/5/20
Crestani NG, Zhou JY, von Drygalski A, et al. | Blood
Aim: To estimate the actual incidences of VTE (including pulmonary embolism (PE), deep vein thrombosis (DVT)) during hospitalization for COVID-19.
CLINICAL CHARACTERISTICS
11/4/20
Wu Z, Yang D | Eur J Med Res
Aim: To explore the probable clinical severity and mortality of COVID-19 patients and their liver dysfunction.
CLINICAL CHARACTERISTICS
11/3/20
Zhou Y, Ren Q, Chen G, et al.  | Front Med
Aim: To review the evidence on the clinical characteristics of COVID-19 patients, with a focus on the prevalence of CKD and AKI, as well as their association with poor prognosis.
CLINICAL CHARACTERISTICS
11/3/20
Lakbar I, Luque-Paz D, Mege J, et al. | PLoS One
Aim: To systematically review the literature relating to men versus women on SARS-CoV-2 in order to seek differences in disease characteristics (e.g. infectivity, severity) and outcomes (e.g. mortality).
CLINICAL CHARACTERISTICS
11/3/20
Mesas AE, Cavero-Redondo I, Alvarez-Bueno C, et al. | PLoS One
Aim: To synthesize the results of primary studies and provide pooled effect size estimators for a comprehensive set of potential predictors of in-hospital mortality in patients with confirmed COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/3/20
Lane MY, Winters N, Fregonese F, et al. | PLoS One
Aim: To conduct a systematic review and meta-analysis on the proportion of asymptomatic infection among coronavirus disease 2019 (COVID-19) positive persons and their transmission potential.
UPDATED
CLINICAL CHARACTERISTICS
11/2/20
Ren L, Yu S, Xu W, et al. | J Cardiol
Aim: To address whether there is an association of antihypertensive medications and the incidence and severity of COVID-19. 
CLINICAL CHARACTERISTICS
11/1/20
Wen W, Zhang H, Zhou M, et al. | Eur Rev Med Pharmacol Sci
Aim: To evaluate arrhythmia in patients with severe and non-severe COVID-19 during the current COVID-19 pandemic.
CLINICAL CHARACTERISTICS
11/1/20
Lim JL, Reddy MP, Afroz A, et al. | Resuscitation
Aim: To evaluate the influence of the COVID-19 pandemic on the incidence, process, and outcomes of OHCA.
UPDATED
CLINICAL CHARACTERISTICS
10/30/20
Ghayda RA, Li H, Lee KH, et al. | J Clin Med
Aim: To synthesize the most up-to-date and relevant available evidence on the outcomes of pregnant women with laboratory-confirmed infection with COVID-19.
CLINICAL CHARACTERISTICS
10/30/20
D'Errico S, Zanon M, Montanaro M, et al. | Microorganisms
Aim: To summarize all autopsy studies up to February 2020 in which a complete post-mortem investigation in patients with COVID-19 disease was performed, focusing on histopathological features. 
CLINICAL CHARACTERISTICS
10/30/20
Dong Z, Xiang B, Jiang M, et al. | Clin Gastroenterol
Aim: To investigate the prevalence of GI symptoms, abnormal liver function, digestive system disease and liver disease in patients with COVID-19 by a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
10/29/20
Munteanu C, Paun D, Suta A, et al. | Balneo Research Journal
Aim: To identify the main possible interferences between DM and COVID-19's pathological mechanisms, and to discuss the value of physical and rehabilitation medicine and balneotherapy in the post-acute COVID-19 recovery of the surviving patients
CLINICAL CHARACTERISTICS
10/29/20
Aggarwal G, Lippi G, Lavie CJ, et al.  | J Diabetes
Aim: To evaluate the potential assocations between diabetes mellitus and infection severity outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/29/20
Khan M, Khan N, Mustagir G, et al. | J Glob Health
Aim: To summarize pre-existing comorbidities in patients with COVID-19, and to estimate the likelihood of mortality from COVID-19 with each category of pre-existing comorbidities.
UPDATED
CLINICAL CHARACTERISTICS
10/29/20
Ramos-Lopez O, Daimiel L, de Molina AR, et al. | Int J Genomics
Aim: To systematically explore genetic polymorphisms associated with the clinical outcomes in SARS-CoV infection in humans.
CLINICAL CHARACTERISTICS
10/29/20
Mohammadi M, Rajabnia M, Abdehagh M | Sci J Kurd Univ Med Sci
Aim: To review the gastrointestinal manifestations in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/29/20
Hasan I, Saif-Ur-Rahman KM, Hayat S, et al. | J Peripher Nerv Syst
Aim: To summarize and meta?analyze the salient features and prognosis of SARS?CoV?2?associated GBS.
CLINICAL CHARACTERISTICS
10/29/20
Asghar M, Hussan N, Shoaib H, et al. | J Community Hosp Intern Med Perspect
Aim: To assess hematological changes seen in COVID-19 infection and their association with the severity of the disease.
CLINICAL CHARACTERISTICS
10/29/20
Milby KM, Atallah AN, Rocha-Filho CR, et al. | Sao Paulo Med J
Aim: To understand and summarize the evidence relating to clinical manifestations, disease severity and prognoses among patients coinfected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and arboviruses.
UPDATED
CLINICAL CHARACTERISTICS
10/27/20
Wijeratne T, Sales C, Karimi L, et al.  | Front Neurol
Aim: To review the clinical data on all published cases of COVID-19 and concomitant AIS, with a view to understanding the pertinent clinical, laboratory and imaging features.
CLINICAL CHARACTERISTICS
10/27/20
Lu Q, Wang Z, Yin Y, et al. | Front Med
Aim: To investigate the evidence on the association between peripheral lymphocyte levels and the progression and mortality of COVID-19.
CLINICAL CHARACTERISTICS
10/27/20
Nannoni S, de Groot R, Bell S, et al.  | Int J Stroke
Aim: To characterize the incidence, risk factors, clinical-radiological manifestations and outcome of COVID-19-associated stroke.
CLINICAL CHARACTERISTICS
10/27/20
Mehraeen E, Karimi A, Barzegary A, et al.  | Eur J Integr Med
Aim: To systematically review the assessment of risk and model the predictors of mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/27/20
Chen X, Zhang G, Hao SY, et al. | Chin Med Sci J
Aim: To compare the similarities and differences of early CT manifestations of three types of viral pneumonia induced by SARS-CoV-2 (COVID-19), SARS-CoV (SARS) and MERS-CoV (MERS) using a systemic review.
CLINICAL CHARACTERISTICS
10/27/20
Szegedi I, Orbán-Kálmándi R, Csiba L, et al. | J Clin Med
Aim: To summarize the available literature on COVID-19-associated coagulopathy and thrombosis and to identify the characteristics of stroke in COVID-19.
CLINICAL CHARACTERISTICS
10/27/20
Pranata R, Supriyadi R, Huang I, et al.  | Clin Med Insights Circ Respir Pulm Med
Aim: To evaluate the association between chronic kidney disease (CKD) and new onset renal replacement therapy (RRT) with the outcome of Coronavirus Disease 2019 (COVID-19) in patients.
CLINICAL CHARACTERISTICS
10/27/20
Bansal A, Singh AD, Jain V, et al.  | Heart & Lung
Aim: To determine if D-dimers are elevated in individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who have adverse clinical outcomes including all-cause mortality, intensive care unit (ICU) admission or acute respiratory distress syndrome (ARDS).
CLINICAL CHARACTERISTICS
10/27/20
Valencia-Enciso N, Ortiz-Pereira M, Zafra-Sierra MP, et al. | J Stroke Cerebrovasc Dis
Aim: To assess the temporal relationship between COVID-19 severity and stroke onset. To determine if characteristics such as presentation of the stroke, younger age, involvement of large vessel occlusion and pattern of paraclinical markers could be distinct from the no-COVID-19 population.
CLINICAL CHARACTERISTICS
10/26/20
Zeng L, Wang S, Cai J, et al. | Epidemiol Infect
Aim: To determine the potential risk factors for cardiac injury complicated COVID-19 virus infection.
CLINICAL CHARACTERISTICS
10/26/20
Yee JY, Kim WK, Han JMH, et al. | Sci Rep
Aim: To evaluate the impact of COVID-19 on pregnant women.
UPDATED
CLINICAL CHARACTERISTICS
10/26/20
Gu ZC, Zhang C, Kong LC, et al. | Cardiovasc Diagn Ther
Aim: To summarize all available evidence for a comprehensive and rigorous systematic review focused on myocardial injury incidence in COVID-19. In addition, to state the case-fatality rate related to cardiac injury, variations of myocardial injury incidence were also examined by disease severity (non-survivors, severe patients, and non-severe patients).
CLINICAL CHARACTERISTICS
10/26/20
Malik P, Patel U, Patel K, et al. | J Med Virol
Aim: To assess the effect of obesity on outcomes in the COVID-19 hospitalizations.
CLINICAL CHARACTERISTICS
10/26/20
Javanmardi F, Keshavarzi A, Akbari A, et al. | PLoS One
Aim: To evaluate the prevalence of underlying disease in died people with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
10/26/20
Vazzana N, Dipaola F, Ognibene S | Acta Clin Belg
Aim: To review the prognostic value of procalcitonin for severe disease and adverse outcome events in COVID-19.
CLINICAL CHARACTERISTICS
10/23/20
Bwire GM, Nijiro BJ, Mwakawanga DL, et al. | J Med Virol
Aim: To determine the likelihood of vertical transmission among COVID-19 exposed infants and to determine whether antibodies against Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/ COVID-19 virus exist among COVID-19 vertically exposed but negative infants.
CLINICAL CHARACTERISTICS
10/23/20
La Distia Nora R, Putera I, Khalisha DF, et al. | BMJ Open Ophthalmol
Aim: To review and critically appraise the ocular manifestation and the presence of SARS-CoV-2 through PCR positivity from ocular samples in COVID-19-related patients. Moreover, to evaluate the time and severity association of ocular manifestation to systemic disease of COVID-19.
CLINICAL CHARACTERISTICS
10/23/20
Yamakawa M, Kuno T, Mikami T, et al. | J Stroke Cerebrovasc Dis
Aim: To depict the frequency and clinical characteristics of COVID-19 patients with stroke.
CLINICAL CHARACTERISTICS
10/23/20
Guo L, Shi Z, Zhang Y, et al. | Diabetes Res Clin Pract
Aim: To assess the association of comorbid diabetes with COVID-19 severity or mortality in China.
CLINICAL CHARACTERISTICS
10/23/20
Wang JG, Cui HR, Tang HB, et al. | Sci Rep
Aim: To understand the clinical manifestations and incidence of gastrointestinal symptoms of Coronavirus disease (COVID-19) in children and discuss the importance of fecal nucleic acid testing.
UPDATED
CLINICAL CHARACTERISTICS
10/23/20
Favas TT, Dev P, Chaurasia RN, et al. | Neurol Sci
Aim: To estimate the proportion of COVID-19 patients developing neurological manifestations.
CLINICAL CHARACTERISTICS
10/23/20
Wang C, Zhang H, Zhou Y, et al. | Eur Rev Med Pharmacol Sci
Aim: To explore the relationship between the prognosis of COVID-19 patients and thromboembolic events.
CLINICAL CHARACTERISTICS
10/22/20
Sepandi M, Taghdir M, Alimohamadi Y, et al. | Iran J Public Health
Aim: To identify effective factors on the death among COVID-19 patients.
CLINICAL CHARACTERISTICS
10/22/20
Ibrahim W | CNS Spectr
Aim: To systematically assess the neurological manifestations in patients diagnosed with COVID-19
CLINICAL CHARACTERISTICS
10/22/20
Haradaa G, Antonacio FF, Gongora AB, | Ecancermedicalscience
Aim: To address the question of whether to test asymptomatic cancer patients before initiating systemic cancer treatments.
CLINICAL CHARACTERISTICS
10/21/20
Leisman DE, Ronner L, Pinotti R, et al. | Lancet Respir Med
Aim: To synthesise and describe the reported pattern of inflammatory cytokines in COVID-19-induced respiratory failure and to compare this profile with those of other acute inflammatory syndromes.
UPDATED
CLINICAL CHARACTERISTICS
10/21/20
Cheng L, Li H, Li L, et al. | J Clin Lab Anal
Aim: To determine the role of ferritin in COVID?19.
CLINICAL CHARACTERISTICS
10/21/20
Kefale B, Tegegne GT, Degu A, et al. | Clin Appl Thromb Hemost
Aim: To investigate the extent and risk factors of thromboembolism among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
10/21/20
Xu J, Teng Y, Shang L, et al. | Clin Infect Dis
Aim: To provide a comprehensive summarization of current evidence to answer two major clinical questions: (1) Does the prior treatment of ACEI/ARB alter the susceptibility of SARS-CoV-2 infection in general population? (2) Does the prior treatment of ACEI/ARB affect risk of mortality and severe outcomes in COVID-19 patients?
UPDATED
CLINICAL CHARACTERISTICS
10/20/20
Yonas E, Alwi I, Pranata R, et al. | Am J Emerg Med
Aim: To investigate the association between heart failure (HF) and poor outcome in patients with COVID-19.
CLINICAL CHARACTERISTICS
10/20/20
Gungor B, Atici A, Baycan OF, et al. | Am J Emerg Med
Aim: To investigate the correlation of D-dimer levels measured on admission with disease severity and the risk of death in patients with coronavirus disease 2019 (COVID-19) pneumonia.
CLINICAL CHARACTERISTICS
10/20/20
Tan E, Song J, Deane AM, et al. | Chest
Aim: To review the evidence on the global point estimate of mortality and risk factors for patients admitted to intensive care units (ICUs) with severe COVID-19.
CLINICAL CHARACTERISTICS
10/20/20
Wassie GT, Azene AG, Bantie GM, et al. | Curr Ther Res Clin Exp
Aim: To estimate the pooled average incubation period of SARS-CoV-2.
CLINICAL CHARACTERISTICS
10/20/20
Chua TH, Xu Z, King NKK | Brain Inj
Aim: To determine the clinical characteristics of neurological manifestations in COVID-19.
CLINICAL CHARACTERISTICS
10/19/20
Liu Y, Lu H, Wang W, et al. | Expert Rev Anticancer Ther
Aim: To identify the risk factors for death in patients with cancer and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
10/19/20
Mulchandani R, Lyngdoh T, Kakkar AK | Eur J Clin Invest
Aim: To quantify the differences in the circulating levels of major inflammatory and immunological markers between severe and non?severe COVID?19 patients.
UPDATED
CLINICAL CHARACTERISTICS
10/19/20
Jena A, Kumar-M P, Singh AK, et al. | Dig Liver Dis
Aim: To study the elevations of fecal calprotectin in COVID-19 and if these elevations were different in patients with or without gastrointestinal symptoms.
CLINICAL CHARACTERISTICS
10/19/20
Abate SM, Mantefardo B, Basu B | Patient Saf Surg
Aim: To provide the global prevalence of perioperative outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
10/19/20
Chamseddine RS, Wahbeh F, Chervenak F, et al. | J Pregnancy
Aim: To review the evidence on preinatal and obstetric management in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
10/19/20
Raschetti R, Vivanti AJ, Vauloup-Fellous C, et al. | Nat Commun
Aim: To clarify the main transmission route, clinical features and outcomes of neonatal SARS-CoV-2 infections
UPDATED
CLINICAL CHARACTERISTICS
10/18/20
Walker C, Deb S, Ling H, et al. | J Pharm Pharm Sci
Aim: To assess the association between elevated cardiac biomarkers and the severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
10/17/20
Zhang P, Shi L, Xu J, et al.  | Immunogenetics
Aim: To evaluate the association of interleukin-6 (IL-6) level with the poor outcomes in coronavirus disease 2019 (COVID-19) patients. 
CLINICAL CHARACTERISTICS
10/16/20
Bhatia R, Pedapati R, Komakula S, et al. | J Stroke
Aim: To report the characteristics of stroke in patients with COVID-19.
CLINICAL CHARACTERISTICS
10/15/20
Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the epidemiologic relationship between smoking and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
10/15/20
Apostolopoulou A, Garrigos ZE, Vijayvargiya P, et al. | Diagnostics
Aim: To investigate the epidemiology, pathogenesis, risk factors, clinical manifestations, diagnosis, treatment and prognosis of COVID-19 associated pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
10/15/20
Akiyama S, Hamdeh S, Micic D, et al. | Ann Rheum Dis
Aim: To assess the prevalence and clinical outcomes of COVID-19 in autoimmune diseases.
CLINICAL CHARACTERISTICS
10/15/20
Du M, Lin Y, Yan W, et al. | World J Diabetes
Aim: To systematically evaluate the prevalence of diabetes among COVID-19 patients in China and its impact on clinical outcomes, including ICU admission, progression to severe cases, or death.
CLINICAL CHARACTERISTICS
10/15/20
Walsh KA, Spillane S, Comber L, et al. | J Infect
Aim: To summarise the evidence on the duration of infectiousness of individuals in whom SARS-CoV-2 ribonucleic acid is detected.
CLINICAL CHARACTERISTICS
10/14/20
Pang KW, Chee J, Subramaniam S, Ng CL | Curr Allergy Asthma Rep
Aim: To quantify the clinical utility of identifying OD in the diagnosis of COVID-19 and determine an estimate of the frequency of OD amongst these patients.
CLINICAL CHARACTERISTICS
10/13/20
Bansal A, Singh AD, Jain V, et al. | Heart Lung
Aim: To determine if D-dimers are elevated in individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who have adverse clinical outcomes including all-cause mortality, intensive care unit (ICU) admission or acute respiratory distress syndrome (ARDS).
UPDATED
CLINICAL CHARACTERISTICS
10/13/20
Pormohammad A, Ghorbani S, Khatami A, et al. | Rev Med Virol
Aim: To compare clinical symptoms, laboratory findings, radiographic signs and outcomes of COVID?19 and influenza to identify unique features.
CLINICAL CHARACTERISTICS
10/13/20
Singh H, Kaur H, Singh K, et al. | Adv Wound Care
Aim: To review the evidence on cutaneous manifestations reported in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/13/20
Nugroho J, Wardhana A, Mulia EP, et al.  | Clin Hemorheol Microcirc
Aim: To determine the relationship between fibrinogen and FDP with poor outcome in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/13/20
Sajid MI, Awais S, Salar K, et, al. | Biomedica
Aim: To evaluate the pathogenesis, risk factors, diagnosis and management strategies in pregnant women suspected or confirmed with COVID-19 infection.
CLINICAL CHARACTERISTICS
10/13/20
Tamuzi JL, Ayele BT, Shumba CS, et al. | BMC Infect Dis
Aim: To review different studies on SARS-CoV, MERS-CoV or COVID-19 associated with HIV/TB co-infection or only TB and to understand the interactions between HIV, TB and COVID-19 and its implications on the burden of the COVID-19 among HIV/TB co-infected or TB patients, screening algorithm and clinical management.
UPDATED
CLINICAL CHARACTERISTICS
10/13/20
Malaty M, Kayes T, Amarasekera AT, et al. | Eur J Clin Invest
Aim: To examine the current incidence and available treatment for arrhythmias in hospitalized patients with SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
10/13/20
Gidari A, Nofri M, Saccarelli L, et al. | Eur J Clin Microbiol Infect Dis
Aim: To review the evidence on the recurrence of coronavirus disease 2019.
CLINICAL CHARACTERISTICS
10/13/20
Hariri LP, North CM, Shih AR, et al. | Chest
Aim: To review the evidence on the lung histopathology described in COVID-19 compared to SARS and H1N1 influenza.
CLINICAL CHARACTERISTICS
10/13/20
Nopp S, Moik F, Jilma B, et al. | Res Pract Thromb Haemost
Aim: To evaluate available data and estimating the prevalence of VTE in COVID?19 patients.
UPDATED
CLINICAL CHARACTERISTICS
10/13/20
Singh S, Desai R, Gandhi Z, et al. | SN Compr Clin Med
Aim: To identify COVID-19-associated TTS case reports and evaluate patient-level demographics, clinical attributes, and outcomes. 
CLINICAL CHARACTERISTICS
10/13/20
Elsayed S, Reddy M, Murthy PM, et al. | Cureus
Aim: To identify the trends of COVID-19 relapse, the effects of co-morbidities on it, and associated mortality rates.
UPDATED
CLINICAL CHARACTERISTICS
10/12/20
Ali AHM, Mohamed SOO, Elkhidir IHE, et al. | Sudan J Med Sci
Aim: To investigate the association of lymphocyte count, CRP, LDH, and D-Dimer with the severity of COVID-19.
CLINICAL CHARACTERISTICS
10/9/20
Abate BB, Kassie AM, Kassaw MW, et al. | BMJ Open
Aim: To assess the sex difference in the prevalence of COVID-19 confirmed cases.
CLINICAL CHARACTERISTICS
10/8/20
Maiese A, Manetti AC, La Russa R, et al. | Forensic Sci Med Pathol
Aim: To collect the currently available pathological data on COVID-19 and review the international literature on the postmortem findings of patients with COVID-19.
CLINICAL CHARACTERISTICS
10/8/20
Quesada JA, López-Pineda A, Gil-Guillén VF, et al. | Rev Clin Esp
Aim: To provide a more accurate estimate of the incubation period of COVID-19.
CLINICAL CHARACTERISTICS
10/8/20
Oliveira CB, Lima CAB, Vajgel G, et al. | J Clin Pathol
Aim: To describe the incidence of AKI, need for renal replacement therapy (RRT) and mortality among patients with COVID-19-associated AKI.
CLINICAL CHARACTERISTICS
10/8/20
Choi GJ, Kim HM, Kang H, et al. | J Lipid Atheroscler
Aim: To analyze the available knowledge about the potential association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) as reported in previous published systematic reviews.
UPDATED
CLINICAL CHARACTERISTICS
10/7/20
Miller L, Bhattacharyya R, Miller AL | Medicine
Aim: To determine the mortality rate of hospitalized patients with Covid-19 in China and to identify factors that may potentially influence this rate.
CLINICAL CHARACTERISTICS
10/7/20
Setiati S, Harimurti K, Safitri ED, et al | Acta Med Indones
Aim: To systematically review all relevant studies related to the risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
10/7/20
Muacevic A, Adler JR | Cureus
Aim: To examine the association between smoking and mortality in COVID-19.
CLINICAL CHARACTERISTICS
10/7/20
Luo L, Fu M, Li Y, et al. | Clin Cardiol
Aim: To assess the association between underlying comorbidities and acute cardiac injury and the severity or the prognosis in COVID?19 patients.
CLINICAL CHARACTERISTICS
10/6/20
Yekeduz E, Utkan G, Urun Y | Eur J Cancer
Aim: To evaluate cancer treatment’s effect on the severity of COVID-19.
CLINICAL CHARACTERISTICS
10/6/20
Mandal A, Nandi S, Chhebbi M, et al. | Indian J Otolaryngol Head Neck Surg
Aim: To review the current guidelines and safety measures to be followed during tracheostomy in COVID-19 infected patients.
CLINICAL CHARACTERISTICS
10/6/20
Kamel AM, Sobhy M, Magdy N, et al. | Rev Med Virol
Aim: To investigate the association between AC and outcomes in hospitalized Covid?19 patients.
CLINICAL CHARACTERISTICS
10/6/20
Tu TM, Goh C, Tan YK, et al. | J Stroke Cerebrovasc Dis
Aim: To perform a systematic review of known cases of concomitant COVID-19 infection and CVT in the current literature.
CLINICAL CHARACTERISTICS
10/6/20
Cheong KX | Curr Ophthalmol Rep
Aim: To summarise and discuss the current literature regarding ocular involvement of SARS-CoV-2 in COVID-19.
CLINICAL CHARACTERISTICS
10/5/20
Meyerowitz-Katz G, Merone L | Int J Infect Dis
Aim: To review the evidence on infection-fatality rates for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
10/5/20
Soeroto AY, Soetedjo NN, Purwiga A, et al. | Diabetes Metab Syndr
Aim: To evaluate the association between obesity and composite poor outcome in coronavirus disease 2019 (COVID-19) patients.
UPDATED
CLINICAL CHARACTERISTICS
10/5/20
Huang Y, Yao L, Huang Y, et al. | Metabolism
Aim: To review the evidence on the effects of obesity with the risk of severe disease among patients with COVID-19.
CLINICAL CHARACTERISTICS
10/5/20
Deng J, Zhou F, Hou W, et al. | Ann N Y Acad Sci
Aim: To assess the prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/2/20
Simoni P, Bazzocchi A, Boitsios G, et al. | J Med Imaging Radiat Oncol
Aim: To describe the chest CT features reported in children with confirmed COVID?19 infection.
CLINICAL CHARACTERISTICS
10/2/20
Jahangir M, Nawaz M, Nanjiani D, et al. | Hong Kong Med J
Aim: To review the characteristics and presentation of COVID-19 among children and describe any subtle characteristics that may strengthen the clinical suspicion of infection and prompt further testing. 
CLINICAL CHARACTERISTICS
10/2/20
Carrillo-Larco RM, Altez-Rodriguez C, Ravaglia S, et al. | Wellcome Open Res
Aim: To understand the characteristics of patients with COVID-19 and GBS, and to identify potential patterns.
UPDATED
CLINICAL CHARACTERISTICS
10/2/20
Mhango M, Dzobo M, Chitungo I, et al. | Saf Health Work
Aim: To map available evidence on Covid-19 risk factors among HWs to guide future research and policy.
CLINICAL CHARACTERISTICS
10/2/20
Rostami M, Mansouritorghabeh H | Expert Rev Hematol
Aim: To analyze the levels of D-dimer in patients with COVID-19.
CLINICAL CHARACTERISTICS
10/2/20
Oliviera Silva DF, Cunha Lima SC, Mauricio Sena-Evangelista KC, et al. | Nutrients
Aim: To identify the screening instruments that can be used to assess nutritional risk in older adults with COVID-19, and to clarify their measurement properties.
UPDATED
CLINICAL CHARACTERISTICS
10/1/20
Jarahzadeh MH, Asadian F, Farbod M, et al. | J Gastrointest Cancer
Aim: To review cancer comorbidity and risk of mechanical ventilation or death in patients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
9/29/20
Hussain N, Chung E, Heyl JJ, et al. | Cureus
Aim: To assess the effects of HCQ on patients with COVID-19.
CLINICAL CHARACTERISTICS
9/29/20
Uygun-Can B, Acar-Bolat B | Biomed Res Int
Aim: To summarize reliable medical evidence by the meta-analysis of all published retrospective studies that examined data based on the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by clinical symptoms, molecular (RT-PCR) diagnosis, and characteristic CT imaging features in pregnant women.
CLINICAL CHARACTERISTICS
9/29/20
Morone G, Palomba A, Iosa M, et al.  | Front Med
Aim: To correlate the presence and the relevant temporal patterns of SARS-CoV-2 viral RNA in biological specimens (stool, urine, blood, and tears) of the transmission with clinical/epidemiological features in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
9/25/20
Singh B, Gornet M, Sims H, et al. | Am J Reprod Immunol
Aim: To analyze the available evidence on SARS-CoV-2 infection, early pregnancy, and reproductive tissues.
CLINICAL CHARACTERISTICS
9/24/20
Bennett S, Tafuro J, Mayer J, et al. | Int J Clin Pract
Aim: To identify the symptoms, comorbidities present, radiological features and outcomes for adults testing positive for COVID?19 admitted to hospital.
CLINICAL CHARACTERISTICS
9/24/20
Lim MA, Pranata R | J Clin Orthop Trauma
Aim: To evaluate the prevalence of coronavirus disease 2019 (COVID-19) and its impact on mortality in patients with hip fracture.
UPDATED
CLINICAL CHARACTERISTICS
9/24/20
Wang Y, Chen J, Chen W, et al. | Int Arch Allergy Immunol
Aim: To explore the literature and collate data comparing the mortality of coronavirus disease 2019 (COVID-19) patients with and without asthma.
CLINICAL CHARACTERISTICS
9/24/20
Murchu EO, Byrne P, Walsh KA, et al. | Rev Med Virol
Aim: To summarize the evidence on the immune response and reinfection rate following SARS?CoV?2 infection. 
CLINICAL CHARACTERISTICS
9/24/20
Roncon L, Zuin M, Barco S, et al. | Eur J Intern Med
Aim: To perform a systematic review and meta-analysis of the in-hospital incidence of acute PE among COVID-19 patients based on studies published within four months of COVID-19 outbreak.
CLINICAL CHARACTERISTICS
9/24/20
Goncalves LF, Gonzales AI, Patatt FSA, et al. | Rev Assoc Med Bras
Aim: To present scientific evidence evaluating the association of Kawasaki Disease (DK) and COVID-19 in children.
CLINICAL CHARACTERISTICS
9/24/20
Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. | PLoS Med
Aim: To review the evidence on asymptomatic SARS-CoV-2 transmission.
CLINICAL CHARACTERISTICS
9/24/20
Nogueira SAR, de Oliveira SCS, de Carvalho AFM, et al. | Rev Assoc Med Bras
Aim: To present a review of renal changes in patients with COVID-19.
CLINICAL CHARACTERISTICS
9/24/20
Ibekew TS, Fasunla AJ, Orimadegun AE | OTO Open
Aim: To estimate prevalence of smell and taste loss among COVID-19 patients.
CLINICAL CHARACTERISTICS
9/24/20
Gulsen A, Yigitbas BA, Uslu B, et al. | Pulm Med
Aim: To determine the relationship between smoking and clinical COVID-19 severity via a systematic meta-analysis approach.
UPDATED
CLINICAL CHARACTERISTICS
9/22/20
Li X, Xu Z, Wang T, et al. | Clin Epidemiol Glob Health
Aim: To identify clinical characteristics of severe patients with COVID-19.
CLINICAL CHARACTERISTICS
9/22/20
Melo-Oliveira ME, Sa-Caputo D, Bachur JA, et al. | Expert Rev Respir Med
Aim: To summarize effects of the COVID-19 in the QoL of the studied populations.
CLINICAL CHARACTERISTICS
9/21/20
Huang AT, Garcia Carreras B, Hitchings MDT, et al. | Nat Commun
Aim: To review the scientific literature on antibody immunity to coronaviruses, including SARS-CoV-2 as well as the related SARS-CoV, MERS-CoV and endemic human coronaviruses (HCoVs). 
UPDATED
CLINICAL CHARACTERISTICS
9/21/20
Marinaki S, Tsiakas S, Korogiannou M, et al. | J Clin Med
Aim: To analyze the data of studies reporting on adult KTx recipients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
9/21/20
Lo KB, Bhargav R, Salacup G, et al. | Expert Rev Cardiovasc Ther
Aim: To investigate the impact of ACEI/ARB on COVID-19 associated disease severity and mortality through a systematic review and meta-analysis of existing literature.
CLINICAL CHARACTERISTICS
9/21/20
Yoon S, Li H, Lee KH, et al. | Medicina
Aim: To compare characteristics among: (1) asymptomatic versus symptomatic and (2) less than 10 versus greater or equal to 10 years old pediatric COVID-19 patients. 
CLINICAL CHARACTERISTICS
9/21/20
Trevisanuto D, Cavallin F, Cavicchiolo ME, et al. | Arch Dis Child Fetal Neonatal Ed
Aim: To summarise currently reported neonatal cases of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
9/21/20
Acheampong DO, Barffour IK, Boye A, et al. | Biomed Pharmacother
Aim: To review the evidence on the possible biological reasons which underpin the differences observed in the outcome of COVID-19 among males and females.
CLINICAL CHARACTERISTICS
9/18/20
Malik P, Patel U, Mehta D, et al. | BMJ Evid Based Med
Aim: To evaluate association between biomarkers and outcomes in COVID-19 hospitalised patients.
CLINICAL CHARACTERISTICS
9/18/20
Pranata R, Huang I, Lim MA, et al. | J Stroke Cerebrovasc Dis
Aim: To evaluate the latest evidence on the association between cerebrovascular, and cardiovascular diseases and poor outcome in patients with Coronavirus Disease 2019 (COVID-19) pneumonia.
CLINICAL CHARACTERISTICS
9/18/20
Orru G, Conversano C, Malloggi E, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the neurological complications of possible neuroinvasion related to SARS-CoV-2.
CLINICAL CHARACTERISTICS
9/18/20
Leung T, Chan A, Chan EW, et al. | Emerg Microbes Infect
Aim: To summarize the current evidence on the short-term adverse health outcomes and assess the risk of potential long-term adverse outcomes of COVID-19. 
CLINICAL CHARACTERISTICS
9/18/20
Fridman S, Bullrich MB, Jimenez-Ruiz A, et al. | Neurology
Aim: To investigate the hypothesis that strokes occurring in patients with COVID-19 have distinctive features.
CLINICAL CHARACTERISTICS
9/18/20
Rajan MB, Kumar P, Bhardwaj A | Int J Dermatol
Aim: To estimate the prevalence of cutaneous manifestations in COVID?19 patients.
CLINICAL CHARACTERISTICS
9/17/20
Pastick KA, Nicol MR, Smyth E, et al. | Open Forum Infect Dis
Aim: To review the available evidence on COVID-19 cases during pregnancy and summarize clinical trials enrolling this population.
CLINICAL CHARACTERISTICS
9/17/20
Macaluso FS, Orlando A | Dig Liver Dis
Aim: To review the evidence on published COVID-19 cases ocurring in patients with IBD.
CLINICAL CHARACTERISTICS
9/17/20
Chang T, Chou C, Chang L | Obes Rev
Aim: To examine the effects of body mass index (BMI) and obesity (BMI ? 30 kg/m2) on coronavirus disease 2019 (COVID?19).
CLINICAL CHARACTERISTICS
9/17/20
Wang Y, Ao G, Qi X, et al  | Clin Exp Allergy
Aim: To review the evidence on the association of asthma with risk of severe or fatal COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
9/17/20
Christophers B, Marin BG, Oliva R et al. | Pediatr Res
Aim: To describe the clinical presentation and outcomes of pediatric patients using an individual patient data approach to visualize trends by age.
UPDATED
CLINICAL CHARACTERISTICS
9/16/20
Du Y, Lv Y, Zha W et al. | Metabolism
Aim: To explore the association between BMI and COVID-19 severity and mortality
CLINICAL CHARACTERISTICS
9/15/20
Peres KC, Riera R, Martimbianco ALC, et al. | Front Endocrinol
Aim: To investigate a possible association between body weight and prognosis among patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
9/15/20
Muhammad SZ, Ahmed A, Shahid I, et al. | Infez Med
Aim: To systematically review these studies and to conduct a meta-analysis of their results to provide a well-powered assessment of chest CT findings in patients with COVID-19.
CLINICAL CHARACTERISTICS
9/15/20
Ciuca IM | Risk Manag Healthc Policy
Aim: To describe the current knowledge about coronavirus disease 2019 (COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) in children, from epidemiological, clinical, and laboratory perspectives, including knowledge on the disease course, treatment, and prognosis.
CLINICAL CHARACTERISTICS
9/15/20
Aziz H, Lashkari N, Yoon YC, et al. | Transplant Proc
Aim: To assess currently published literature relating to the management, clinical course and outcomes of SARS-Cov-2 infection in liver, kidney and heart SOT recipients.
CLINICAL CHARACTERISTICS
9/15/20
Roberto KT, Espiritu AI, Fernandez MLL, et al. | Seizure
Aim: To review the EEG findings in patients diagnosed with COVID-19 infection through a systematic review of published articles.
CLINICAL CHARACTERISTICS
9/15/20
Siepmann T, Sedghi A, Simon E, et al. | Eur J Neurol
Aim: To define the risk of acute stroke in patients with severe and non-severe COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
9/15/20
Zhang A, Leng Y, Zhang Y et al. | Int J Infect Dis
Aim: To figure out whether abnormal coagulation parameters are associated with disease severity and poor prognosis in patients with 2019 Corona Virus Disease (COVID-19)
CLINICAL CHARACTERISTICS
9/15/20
Ahmed M, Advani S, Moreira A, et al. | EClinicalMedicine
Aim: To describe the typical presentation and outcomes of children diagnosed with this hyperinflammatory condition.
UPDATED
CLINICAL CHARACTERISTICS
9/15/20
Nugroho J, Wardhana A, Maghfirah I, et al. | Int J Lab Hematol
Aim: To determine the relationship of a prognostic factor, D?dimer, with disease severity, need for intensive care unit (ICU) care, and mortality in SARS?CoV?2 patients.
CLINICAL CHARACTERISTICS
9/15/20
Banerjee I, Robinson J, Kashyap A, et al. | Nepal J Epidemiol
Aim: To assess the impact of COVID-19 on the younger age group in terms of the Global mortality of COVID-19 in comparison to Nepal. 
CLINICAL CHARACTERISTICS
9/15/20
Aronoff SC, Hall A, Del Vecchio MT | J Pediatric Infect Dis Soc
Aim: To provide a detailed clinical description and natural history of MIS-C.
CLINICAL CHARACTERISTICS
9/14/20
Lee JC, Nallani R, Cass L, et al. | Am J Rhinol Allergy
Aim: To synthesize the existing primary literature related to olfactory dysfunction secondary to viral infection, detail the underlying pathophysiological mechanisms, highlight relevance for the current COVID-19 pandemic, and identify high impact areas of future research.
CLINICAL CHARACTERISTICS
9/14/20
Mark EG, Golden WC, Gilmore MM, et al. | J Pediatr
Aim: To summarize and evaluate current reports on community-onset severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in young infants.
CLINICAL CHARACTERISTICS
9/14/20
Jimenez-Ruiz CA, Lopez-Padilla D, Alonso-Arroyo A, et al. | Arch Bronconeumol
Aim: To review the evidence on the association between tobacco use in patients with COVID-19 and negative progression and adverse outcome of the disease.
CLINICAL CHARACTERISTICS
9/14/20
Williams N, Radia T, Harman K, et al. | Eur J Pediatr
Aim: To identify and describe which underlying comorbidities may be associated with severe SARS-CoV-2 disease and death in children.
CLINICAL CHARACTERISTICS
9/14/20
Di Maria E, Latini A, Borgiani P, et al. | Human Genomics
Aim: To review the evidence on genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS, and COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
9/14/20
Panda PK, Sharawat IK, Panda P, et al. | J Trop Pediatr
Aim: To review the evidence on the neurological manifestations of COVID-19 in children.
UPDATED
CLINICAL CHARACTERISTICS
9/14/20
Nino G, Zember J, Sanchez-Jacob R, et al. | Pediatr Pulmonol
Aim: To provide the first comprehensive summary of the findings of published studies thus far describing COVID-19 lung imaging data in the pediatric population.
CLINICAL CHARACTERISTICS
9/14/20
Florez-Perdomo WA, Serrato-Vargas SA, Bosque-Varela P, et al. | Clin Neurol Neurosurg
Aim: To evaluate and summarize the level of evidence on past history of stroke in COVID19 patients.
CLINICAL CHARACTERISTICS
9/14/20
Patoulias D, Katsimardou A, Stavropoulos K, et a. | Curr Hypertens Rep
Aim: To evaluate the association between the use of either ACE inhibitors or ARBs and the risk for major clinical endpoints (infection, hospitalization, admission to ICU, death) in adult patients during the COVID-19 pandemic. 
CLINICAL CHARACTERISTICS
9/14/20
Elhabyan A, El Yaacoub S, Sanad E, et al. | Virus Res
Aim: To identify the candidate genes that are likely to aid in explaining severe COVID-19 and provide insights to understand severe COVID-19.
CLINICAL CHARACTERISTICS
9/12/20
Noor FM, Islam MM | J Community Health
Aim: To find the prevalence of mortality among hospitalized COVID-19 infected patients and associated risk factors for death.
CLINICAL CHARACTERISTICS
9/11/20
Brienza N, Puntillo F, Romagnoli S, et al. | Blood Purif
Aim: To clarify the incidence and the impact of COVID-19-related AKI on mortality.
CLINICAL CHARACTERISTICS
9/11/20
Ng JJ, Luo Y, Phua K, et al. | J Infect
Aim: To quantitatively synthesized available literature and performed a single-arm meta-analysis of proportions to report the pooled incidence rate of AKI and renal replacement therapy (RRT) use in hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
9/11/20
Patel U, Malik P, Usman MS, et al. | SN Compr Clin Med
Aim: To identify risk factors associated with poor outcomes (IMV and mortality) of COVID-19 hospitalized patients.
CLINICAL CHARACTERISTICS
9/11/20
Paliogiannis P, Mangoni AA, Dettori P, et al. | Front Public Health
Aim: To investigate differences in serum D-dimer concentrations in patients with and without severe COVID-19 disease. 
CLINICAL CHARACTERISTICS
9/11/20
Zhao G, Huang P, Du B, et al. | Nutr Metab Cardiovasc Dis
Aim: To 1) explore the prevalence of cardiac injury in different types of COVID-19 patients and 2) evaluate the association between cardiac injury and worse prognosis (severe disease, admission to ICU, and mortality) in patients with COVID-19.
CLINICAL CHARACTERISTICS
9/11/20
Seidu S, Gillies C, Zaccardi F, et al. | Endocrinol Diabetes Metab
Aim: To determine whether people with overweight or obesity and with SARS?CoV?2 have different outcomes compared to those within normal weight thresholds.
UPDATED
CLINICAL CHARACTERISTICS
9/10/20
Neishaboori AM, Moshrefiaraghi D, Ali KM, et al. | Arch Acad Emerg Med
Aim: To investigate the current evidence regarding central nervous system (CNS) complications in patients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
9/9/20
Fu EL, Janse RJ, de Jong Y, et al. | Clin Kidney J
Aim: To review the evidence on incidence, mortality and risk factors for acute kidney injury in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
9/9/20
Gitterman LMT, Feris SNV, von Oetinger Giocoman A | Neurologia
Aim: To analyze the available evidence on patients with Guillain-Barre syndrome associated with COVID-19.
CLINICAL CHARACTERISTICS
9/8/20
Wong Y, Tan M, Zheng Q, et al. | Ann Hepatol
Aim: To assess the prevalence and degree of liver injury between patients with severe and non-severe COVID-19.
CLINICAL CHARACTERISTICS
9/8/20
Miller MA, Cappuccio F | Sleep Med Rev
Aim: To review the rapidly emerging COVID-19 literature to determine (a) the relationship between obstructive sleep apnoea (OSA) and adverse COVID-19 outcomes and, (b) potential causal mechanisms (c) what effect COVID-19 has had on OSA diagnosis and (d) what effect COVID-19 has had on treatment and management of OSA during this period. 
CLINICAL CHARACTERISTICS
9/8/20
Kaushik A, Gupta S, Sood M, et al. | Pediatr Infect Dis J
Aim: To review the evidence on multisystem inflammatory syndrome in children (MIS-C).
CLINICAL CHARACTERISTICS
9/8/20
Hartmann-Boyce J, Gunnell J, Drake J, et al. | BMJ Evid Based Med
Aim: To assess the risks and management considerations of COVID-19 in people with asthma (PWA).
CLINICAL CHARACTERISTICS
9/8/20
Fraser J, Mousley J, Testro A, et al. | Transplant Proc
Aim: To review the evidence on the clinical presentation, treatments, and outcomes in liver transplant recipients with COVID-19.
CLINICAL CHARACTERISTICS
9/8/20
Shoar S, Hosseini F, Naderan M, et al. | Am J Cardiol
Aim: To review the evidence on cardiovascular complications associated with COVID-19.
CLINICAL CHARACTERISTICS
9/8/20
Radia T, Williams N, Agrawal P, et al. | Paediatr Respir Rev
Aim: To evaluate reported cases of MIS-C in children and adolescents.
CLINICAL CHARACTERISTICS
9/8/20
Diriba K, Awulachew E, Getu E | Eur J Med Res
Aim: To assess the effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and its possibility of vertical maternal–fetal transmission.
CLINICAL CHARACTERISTICS
9/7/20
Simadibrata DM, Lubis AM | Epidemiol Infect
Aim: To review and evaluate currently available evidence to establish the association between D-dimer levels on admission and all-cause mortality risk in patients with COVID-19.
CLINICAL CHARACTERISTICS
9/4/20
Keller KG, Reangsing C, Schneider JK | J Adv Nurs
Aim: To 1) determine the clinical presentation and 2) outcomes of adult hospitalized patients with COVID-19 to provide practicing nurses with a cogent and concise clinical impression of COVID-19 patients.
CLINICAL CHARACTERISTICS
9/4/20
Rees EM, Nightingale ES, Jafari Y, et al. | BMC Med
Aim: To review estimates of how long patients with COVID-19 need different levels of hospital care.
UPDATED
CLINICAL CHARACTERISTICS
9/4/20
Ghoda A, Ghoda M | Cureus
Aim: To ascertain whether liver enzyme derangement is a common feature in adult patients with confirmed COVID-19 infection, determine the relation of deranged liver enzymes with outcome or mortality in COVID-19, and determine if liver failure is a common feature of COVID-19.
CLINICAL CHARACTERISTICS
9/3/20
Giorli A, Ferretti F, Biagini C, et al. | Curr Treat Options Neurol
Aim: To investigate the association between the olfactory dysfunction and the more typical symptoms (fever, cough, dyspnoea) within the Sars-CoV-2 infection (COVID-19) in hospitalized and non-hospitalized patients.
CLINICAL CHARACTERISTICS
9/3/20
Caldeira D, Alves M, Melo RGE, et al. | Int J Cardiol Heart Vasc
Aim: To systematically evaluate the risk of COVID-19 infection and the risk of severe COVID-19 disease associated with previous exposure to (ACEi) and/or ARB).
UPDATED
CLINICAL CHARACTERISTICS
9/3/20
Liu C, He Y, Liu L, et al. | BMC Pediatr
Aim: To review the evidence on the characteristics of children with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
9/3/20
Zhang Z, Zhang L, Zha D, et al. | Ren Fail
Aim: To evaluate the clinical characteristics and possible risk factors affecting the progression of disease in COVID-19 patients with AKI.
CLINICAL CHARACTERISTICS
9/3/20
de Barcelos Ubaldo Martins L, Jabour LGPP, Vieira CC, et al. | Curr Med Chem
Aim: To describe the particularities of the RAS and the immune system profile of particular subgroups of patients.
CLINICAL CHARACTERISTICS
9/3/20
Costenaro P, Minotti C, Barbieri E, et al. | Rev Med Virol
Aim: To review the current knowledge on SARS-CoV-2 cases in PLWHA.
UPDATED
CLINICAL CHARACTERISTICS
9/3/20
de Almeida-Pititto B, Dualib PM, Zajdenverg L, et al. | Diabetol Metab Syndr
Aim: To evaluate the association of diabetes, hypertension, cardiovascular disease and ACEI/ARBs exposure with severity–intensive care unit treatment or mechanical ventilation necessity or O2 saturation?
UPDATED
CLINICAL CHARACTERISTICS
9/2/20
Cheruiyot I, Kipkorir V, Ngure B, et al. | Ann Vasc Surg
Aim: To identify and consolidate evidence of AT in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/2/20
Saini KS, Tagliamento M, Lambertini M, et al. | Eur J Cancer
Aim: To provide precise estimates of the mortality rate among patients with both cancer and COVID-19.
CLINICAL CHARACTERISTICS
9/1/20
Sakka M, Conners JM, Hekimian G, et al. | J Med Vasc
Aim: To review current available data on the association between D-Dimer levels and mortality in patients admitted to hospital for COVID-19.
CLINICAL CHARACTERISTICS
9/1/20
Vafea MT, Atalla E, Kalligeros M, et al. | Clin Radiol
Aim: To determine the overall rate of chest imaging findings in asymptomatic cases, describe the most common patterns found, and determine the rate of later symptom development in these initially asymptomatic cases.
CLINICAL CHARACTERISTICS
9/1/20
Ahmed J, Rizwan T, Malik F, et al. | Cureus
Aim: To derive generalizable, well-powered estimates of liver injury prevalence in COVID-19 patients. 
CLINICAL CHARACTERISTICS
9/1/20
Park R, Chidharla A, Mehta K, et al. | EClinicalMedicine
Aim: To synthesize the evidence behind sex-bias within COVID-19 associated illness severity and death specifically within the cancer patient population.
CLINICAL CHARACTERISTICS
8/31/20
McBane RD, Roldan VDT, Niven AS, et al. | Mayo Clin Proc
Aim: To synthesize current data on thrombosis risk, prognostic implications, and anticoagulation effects in COVID-19.
CLINICAL CHARACTERISTICS
8/31/20
Ssentongo P, Ssentongo AE, Heilbrunn ES, et al. | PLoS ONE
Aim: To estimate the association of pre-existing comorbidities with COVID-19 mortality.
UPDATED
CLINICAL CHARACTERISTICS
8/31/20
Chi H, Chiu N, Tai Y, et al. | J Microbiol Immunol Infect
Aim: To investigate the outcomes of neonates born to mothers with COVID-19.
CLINICAL CHARACTERISTICS
8/31/20
Pal R, Banerjee M, Yadav U, et al. | Diabetes Metab Syndr
Aim: To conduct a systematic literature review and analyze the demographic/biochemical parameters and clinical outcomes of COVID-19 patients with diabetic ketoacidosis (DKA) and combined DKA/HHS (hyperglycemic hyperosmolar syndrome).
CLINICAL CHARACTERISTICS
8/31/20
Del Sole F, Farcomeni A, Loffredo L, et al. | Eur J Clin Invest
Aim: To systematically review clinical and biochemical characteristics associated with the severity of the novel severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2)?related disease (COVID?19).
CLINICAL CHARACTERISTICS
8/31/20
Uncini A, Vallat J, Jacobs BC | J Neurol Neurosurg Psychiatry
Aim: To clarify the clinical and electrophysiological phenotype, and to discuss, on the basis of the available data, whether the disease mechanism could be parainfective or postinfective and to speculate on the possible pathogenesis.
CLINICAL CHARACTERISTICS
8/31/20
Zhang C, Shen L, Le K, et al. | Front Cardiovasc Med
Aim: To summarize all available evidence for a comprehensive and rigorous systematic review focused on VTE incidence in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
8/31/20
Popkin BM, Du S, Green WD, et al. | Obes Rev
Aim: To review the evidence on the linkage between obesity and COVID-19.
CLINICAL CHARACTERISTICS
8/31/20
Chi H, Chiu N, Peng C, et al. | Life
Aim: To investigate the prevalence of OGA in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/31/20
Jani BD, Pell JP, McGagh D, et al. | BJGP Open
Aim: To collate a comprehensive list of symptoms, assessment items, demographics, and lifestyle and health conditions associated with COVID-19, with proposed corresponding SNOMED CT clinical terms. 
CLINICAL CHARACTERISTICS
8/31/20
Sawalha K, Abozenah M, Kadado AJ, et al. | Cardiovasc Revasc Med
Aim: To describe the clinical characteristics and management of currently published COVID-19 myocarditis patients.
CLINICAL CHARACTERISTICS
8/31/20
Hasani H, Mardi S, Shakerian S, et al. | Biomed Res Int
Aim: To assess the frequency of clinical, laboratory, and imaging featues of COVID-19.
CLINICAL CHARACTERISTICS
8/31/20
Porfidia A, Valeriani E, Pola R, et al. | Thromb Res
Aim: To evaluate the incidence of VTE in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/29/20
Kelada M, Anto A, Dave K, et al. | Cureus
Aim: To assess the role of sex in the risk of mortality from COVID-19 in adult patients through comparison of clinical markers and inflammatory indexes.? 
UPDATED
CLINICAL CHARACTERISTICS
8/28/20
Yu J, Wu B, Yang J, et al. | Biol Res Nurs
Aim: To explore whether cardio-cerebrovascular disease would increase the risk of COVID-19 patients. 
CLINICAL CHARACTERISTICS
8/27/20
Coomes EA, Haghbayan H | Rev Med Virol
Aim: To assess the evidence describing IL-6 response in patients with COVID-19 and the existing and planned studies investigating the efficacy of tocilizumab to guide patient management, clarify guideline development, and inform future trials in this field.
UPDATED
CLINICAL CHARACTERISTICS
8/26/20
Zou F, Qian Z, Wang Y, et al. | CJC Open
Aim: To conduct a comprehensive review and meta-analysis of the incidence, comorbidities, outcomes and possible mechanisms of acute cardiac injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/26/20
Kaur N, Gupta I, Singh H, et al. | SN Compr Clin Med
Aim: To evaluate the epidemiological and clinical characteristics of COVID-19 patients while also highlighting the comorbidities and radiological findings.
CLINICAL CHARACTERISTICS
8/26/20
Abu-Rumeileh S, Abdelhak A, Foschi M, et al. | J Neurol
Aim: To provide a comprehensive and updated overview of all case reports and series of COVID-19-related GBS to identify predominant clinical, laboratory, and neurophysiological patterns and to discuss the possible underlying pathophysiology.
CLINICAL CHARACTERISTICS
8/26/20
Bansal A, Prasad JB | Z Gesundh Wiss
Aim: To quantify the overall risk of liver damage in COVID-19 patients and also find the overall variation in risk outcome.
CLINICAL CHARACTERISTICS
8/26/20
Correia AO, Feitosa PWG, Moreira JLS, et al. | Neurol Psychiatry Brain Res
Aim: To describe the main neurological manifestations related to coronavirus infection in humans.
CLINICAL CHARACTERISTICS
8/26/20
D'Ambrosi R | Indian J Orthop
Aim: To analyze all the articles related to COVID-19 and orthopedics and to shed light on the scientific evidence that has actually been found.
CLINICAL CHARACTERISTICS
8/26/20
Khalil A, Kalafat E, Benlioglu C, et al. | EClinicalMedicine
Aim: To systematically review the available literature on COVID-19 and pregnancy, to provide comprehensive data to care-providers, pregnant women and their families, inform national and international guidelines, and direct the course of ongoing and future studies
CLINICAL CHARACTERISTICS
8/26/20
Davis B, Rothrock AN, Swetland S, et al. | J Am Coll Emerg Physicians Open
Aim: To analyze the prevalence of respiratory pathogens (viruses and atypical bacteria) in COVID?19 patients.
CLINICAL CHARACTERISTICS
8/25/20
Kunutsor SK, Laukkanen JA | Thromb Res
Aim: To review the evidence on the thromboembolic complications associated with COVID-19 and the incidence of severe disease.
CLINICAL CHARACTERISTICS
8/24/20
Puli S, Baig M, Walayat S | Cureus
Aim: To assess gastrointestinal symptoms and liver enzymes trend in corona virus infection.
CLINICAL CHARACTERISTICS
8/24/20
Patanavanich R & Glantz SA | Nicotine & Tobacco Research
Aim: To review the evidence on the association between smoking and progression of the infectious disease COVID-19.
CLINICAL CHARACTERISTICS
8/23/20
Starke KR, Petereit-Haack G, Schubert M, et al. | Int J Environ Res Public Health
Aim: To quantify the isolated effect of age on severe COVID-19 outcomes
CLINICAL CHARACTERISTICS
8/21/20
Taneri PE, Ochoa S, Llanaj E, et al. | Eur J Epidemiol
Aim: To evaluate biomarkers of anemia and iron metabolism (hemoglobin, ferritin, transferrin, soluble transferrin receptor, hepcidin, haptoglobin, unsaturated iron-binding capacity, erythropoietin, free erythrocyte protoporphyrine, and prevalence of anemia) in patients diagnosed with COVID-19, and explore their prognostic value. 
UPDATED
CLINICAL CHARACTERISTICS
8/21/20
Turan O, Hakim A, Dashraath P, et al. | Int J Gynaecol Obstet
Aim: To summarize clinical characteristics and outcomes among pregnant women hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
8/21/20
Shang L, Shao M, Guo Q, et al. | Arch Med Res
Aim: To assess whether diabetes mellitus (DM) would increase the risk of severe infection and death in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/21/20
Deshmukh V, Motwani R, Kumar A, et al. | J Clin Pathol
Aim: To review and summarise the latest histopathological changes in different organs observed after autopsy of COVID-19 cases.
CLINICAL CHARACTERISTICS
8/21/20
Pranata R, Huang I, Raharjo SB | Indian Pacing Electrophysiol J
Aim: To evaluate the incidence of cardiac arrhythmias in patients with COVID-19 and their implications on patient prognosis.
CLINICAL CHARACTERISTICS
8/21/20
Khalili MA, Leisegang K, Majzoub A, et al. | World J Mens Health
Aim: To investigate the current evidence of SARS-CoV-2 impact on male reproduction and pregnancy outcomes, discussing them in light of the evidence published on other coronaviruses.
CLINICAL CHARACTERISTICS
8/20/20
Mahumud RA, Kamara JK, Renzaho AMN | Infection
Aim: To examine the overall distribution of chronic comorbidities in coronavirus disease-19 (COVID-19) infected populations and the risk of the underlying burden of disease in terms of the case fatality ratio (CFR).
CLINICAL CHARACTERISTICS
8/19/20
Ortolan A, Lorenzin M, Felicetti M, et al. | Int J Infect Dis
Aim: To analyse the influence of gender on COVID-19 mortality, severity and disease outcomes. 
CLINICAL CHARACTERISTICS
8/19/20
McAloon C, Collins A, Barber A, et al. | BMJ Open
Aim: To conduct a rapid systematic review and meta-analysis of estimates of the incubation period of COVID-19.
CLINICAL CHARACTERISTICS
8/19/20
Vaja R, chan J, Ferreira P, et al. | Br J Clin Pharmacol
Aim: To evaluate cardiovascular and respiratory complications in patients taking NSAIDs during acute lower respiratory tract infections.
CLINICAL CHARACTERISTICS
8/19/20
Birkeland K, Zimmer R, Kimchi A, et al. | Interact J Med Res
Aim: To estimate VTE incidence in hospitalized patients and to analyze characteristic factors in the VTE cohort.
CLINICAL CHARACTERISTICS
8/17/20
Inomata T, Kitazawa K, Kuno T, et al. | Invest Ophthalmol Vis Sci
Aim: To determine currently reported clinical and prodromal ocular symptoms in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
8/17/20
Labenz C, Toenges G, Worns M, et al. | Eur J Gastroenterol Hepatol
Aim: To review the evidence on published data on liver injury in patients with COVID-19 infection.
CLINICAL CHARACTERISTICS
8/17/20
Dubey P, Reddy SY, Manuel S, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To estimate the adverse maternal and neonatal characteristics and outcomes among COVID-19 infected women and determine heterogeneity in the estimates and associated factors.
CLINICAL CHARACTERISTICS
8/16/20
Hessami K, Homayoon N, Hashemi A, et al. | J Matern Fetal Neonatal Med
Aim: To review the evidence regarding maternal, fetal and neonatal mortality cases associated with COVID-19 infection.
CLINICAL CHARACTERISTICS
8/15/20
Nasiri MJ, Haddadi S, Tahvildari A, et al.  | Front Med
Aim: To better understand role of the sex in mortality of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/15/20
Boregowda U, Aloysius M, Perisetti A, et al. | Front Med
Aim: To compare the serum liver chemistries such as hepatic transaminases, total bilirubin, albumin, and prothrombin time to evaluate whether they can predict severity and mortality in COVID-19.
CLINICAL CHARACTERISTICS
8/14/20
Knisely A, Wu J, Kaplan SJ, et al. | Cancer Invest
Aim: To examine the patterns of clinical presentations and outcomes in patients with cancer with coronavirus-spectrum illness to offer guidance on detection and management of COVID-19 disease in this particularly susceptible cohort of patients.
CLINICAL CHARACTERISTICS
8/14/20
Li J, Huang DQ, Zou B, et al. | J Med Virol
Aim: To determine pooled estimates for clinical characteristics and outcomes in COVID-19 patients including subgroups by disease severity (based on WHO Interim Guidance Report or IDSA/ATS criteria) and by country/region.
CLINICAL CHARACTERISTICS
8/12/20
Moosavi SA, Mashhadiagha A, Hashemazar A, et al. | Transpl Infect Dis
Aim: to conduct a systematic review on COVID?19 clinical manifestations and treatment strategies in SOT recipients.
UPDATED
CLINICAL CHARACTERISTICS
8/12/20
Kasperkiewicz M | J Am Acad Dermatol
Aim: To review the evidence on how the COVID-19 pandemic affects patients with autoimmune bullous diseases.
CLINICAL CHARACTERISTICS
8/11/20
Almutairi A, Alfaleh M, Alasheikh M | Cureus
Aim: To evaluate the medical literature and explore the dermatological clinical manifestations in patients with SARS-CoV-2.
CLINICAL CHARACTERISTICS
8/11/20
Katal S, Johnston SK, Johnston JH, et al. | Acad Radiol
Aim: To review the radiological characteristics of COVID-19 in pediatrics.
CLINICAL CHARACTERISTICS
8/11/20
Robbins-Jaurez SY, Qian L, King KL, et al. | Kidney Int Rep
Aim: To assess the incidence of AKI among patients with COVID-19 and examine their associations with patient outcomes as reported in the available literature thus far.
CLINICAL CHARACTERISTICS
8/11/20
D'Amico F, Danese S, Peyrin-Biroulet L | Clin Gastroenterol Hepatol
Aim: To investigate symptoms and diagnostic-therapeutic management of IBD patients with COVID-19.
CLINICAL CHARACTERISTICS
8/10/20
Pettirosso E, Giles M, Cole S, et al. | Aust N Z J Obstet Gynaecol
Aim: To describe the current understanding of COVID?19 illness in pregnant women, to describe obstetric outcomes and to identify gaps in the existing knowledge.
CLINICAL CHARACTERISTICS
8/10/20
Abrams JY, Godfred-Cato SE, Oster ME, et al. | J Pediatr
Aim: To develop a more comprehensive description of multisystem inflammatory syndrome in children (MIS-C).
CLINICAL CHARACTERISTICS
8/9/20
Cui X, Zhao Z, Zhang T, et al. | J Med Virol
Aim: To provide a comprehensive and systematic analysis of demographic characteristics, clinical symptoms, laboratory findings and imaging features of coronavirus disease 2019 (COVID-19) in pediatric patients.
UPDATED
CLINICAL CHARACTERISTICS
8/9/20
Jutzeler CR, Bourguignon L, Weis CV, et al. | Travel Med Infect Dis
Aim: To gather all available information regarding comorbidities, clinical signs and symptoms, outcomes, laboratory findings, imaging features, and treatments in patients with coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
8/9/20
Neumann-Podczaska A, Al-Saad SR, Karbowski LM, et al. | Aging Dis
Aim: To concisely summarize the clinical features, comorbidities, radiological/laboratory findings, and outcomes in the older adults. 
CLINICAL CHARACTERISTICS
8/9/20
Hoang A, Chorath K, Moreira A, et al. | EClinicalMedicine
Aim: To characterize clinical symptoms, laboratory, and imaging findings, as well as therapies provided to confirmed pediatric cases of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/9/20
Wu T, Zuo Z, Deng M | Aging Dis
Aim: To provide systematic evidence for the association between multiorgan dysfunction and COVID-19 development.
UPDATED
CLINICAL CHARACTERISTICS
8/9/20
Samaranayake L, Fakhruddin K, Panduwawala C | Acta Odontol Scand
Aim: To evaluate the contemporary evidence on dysgeusia and anosmia as trigger prodromal symptoms, and their prevalence in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/9/20
Sanchez-Ramirez DC, Mackey D | Respir Med
Aim: To explore the association of underlying respiratory diseases and smoking with severe outcomes in patients with COVID-19 infection.
CLINICAL CHARACTERISTICS
8/8/20
Patel U, Malik P, Shah D, et al. | J Neurol
Aim: To evaluate the outcomes of COVID-19 patients with pre-existing CeVD.
CLINICAL CHARACTERISTICS
8/7/20
Zheng B, Wang H, Yu C | Pediatr Pulmonol
Aim: To systematically review the current situation and public health burden associated with children infected with SARS-CoV2.
CLINICAL CHARACTERISTICS
8/7/20
Wu X, Liu L, Jiao J, et al. | Ann Med
Aim: To review the evidence on clinical, laboratory and imaging factors related to mild vs. severe COVID-19 infection.
CLINICAL CHARACTERISTICS
8/7/20
De Sanctis P, Doneddu PE, Vigano L, et al. | Eur J Neurol
Aim: To identify specific clinical features of GBS associated with COVID-19.
CLINICAL CHARACTERISTICS
8/7/20
Salunke AA, Nandy K, Pathak PK, et al. | Diabetes Metab Syndr
Aim: To evaluate the impact of cancer on serious events including ICU admission rate and mortality in COVID 19.
CLINICAL CHARACTERISTICS
8/7/20
Sharifian-Dorche M, Huot P, Osherov M, et al. | J Neurol Sci
Aim: To review the neurological complications of CoV infection in humans.
CLINICAL CHARACTERISTICS
8/3/20
Shao M, Li X, Liu F, et al. | Pharmacol Res
Aim: To investigate whether the presence of acute kidney injury (AKI) might increase the risk of severe infection and fatality in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/3/20
Wu B, Gu D, Yu J, et al. | Infect Genet Evol
Aim: To delve into the association between ABO blood group and COVID-19 infection, severity and demise.
CLINICAL CHARACTERISTICS
8/3/20
Sales-Peres SHC, de Azevedo-Silva LJ, Bonato RCS, et al. | Obes Res Clin Pract
Aim: To investigate the relationship between coronavirus disease 2019 (COVID-19) and obesity in critically ill patients admitted to the intensive care unit (ICU).
UPDATED
CLINICAL CHARACTERISTICS
8/3/20
Carlo D, Montemurro N, Petrella G, et al. | J Neurol
Aim: To review the evidence on the spectrum of neurological symptoms experienced by COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/3/20
Zuin M, Rigatelli G, Zuliani G, et al. | J Cardiovasc Med
Aim: To investigate the relationship between ACI and mortality risk in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/3/20
Rocke J, Hopkins C, Philpott C, et al. | Clin Otolaryngol
Aim: To systematically review the currently available evidence investigating the association between olfactory dysfunction (OD) and the novel coronavirus (COVID-19).
CLINICAL CHARACTERISTICS
8/3/20
Kotlyar A, Grechukihina O, Chen A, et al | Am J Obstet Gynecol
Aim: To determine estimates of vertical transmission of COVID-19 based upon early RNA detection of SARS-CoV-2 after birth from various neonatal/fetal sources and neonatal serology.
CLINICAL CHARACTERISTICS
8/2/20
de Siqueira JVV, Almeida LG, Zico BO | Obes Res Clin Pract
Aim: To assess whether there was an association between obesity and higher levels of hospitalization, poor outcomes and mortality due to the disease of novel coronavirus (COVID-19).
CLINICAL CHARACTERISTICS
8/2/20
Rooney S, Webster A, Paul L | Phys Ther
Aim: To 1) compare physical function and fitness outcomes in people infected with SARS-CoV to healthy controls; 2) quantify the recovery of physical function and fitness following SARS-CoV infection; 3) determine the effects of exercise following SARS-CoV infection.
CLINICAL CHARACTERISTICS
8/1/20
Qiu P, Zhou Y, Wang F, et al. | Aging Clin Exp Res
Aim: To find risk factors for the COVID-19-related death, helping to enhance the efficacy and reduce the mortality of COVID-19.
CLINICAL CHARACTERISTICS
8/1/20
Awulachew E, Diriba K, Anja A, et al. | Radiol Res Pract
Aim: To systematically analyze the existing literature on CT imaging features of patients with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
8/1/20
Mirzaei H, McFarland W, Karamouzian M, et al. | AIDS Behav
Aim: To review the evidence on the earliest patients with COVID-19-HIV co-infection.
CLINICAL CHARACTERISTICS
8/1/20
Pranata R, Soeroto AY, Huang I, et al. | Int J Tuberc Lung Dis
Aim: To investigate the association between chronic obstructive pulmonary disease (COPD) and smoking with outcome in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/1/20
Baradaran A, Ebrahimzadeh MH, Baradaran A, et al. | Arch Bone Jt Surg
Aim: To assess the prevalence of comorbidities in the confirmed COVID-19 patients.
CLINICAL CHARACTERISTICS
8/1/20
Liu H, Gai S, Wang X et al. | Cardiovasc Res
Aim: To analyse ACE2 and SARS-CoV-2 spike (S) protein proteases at the single-cell level, to explore the cardiac involvement in COVID-19 and improve our understanding of the potential cardiovascular implications of COVID-19.
CLINICAL CHARACTERISTICS
8/1/20
Akbari H, Tabrizi R, Lankarani KB, et al. | Life Sci
Aim: To make a comparison between the clinical laboratory-related factors, complete blood count (CBC) indices, cytokines, and lymphocyte subsets in order to distinguish severe coronavirus disease 2019 (COVID-19) cases from the non-severe ones.
UPDATED
CLINICAL CHARACTERISTICS
8/1/20
Zhang L, Peres TG, Silva MVF et al. | Pediatr Pulmonol
Aim: To summarize what we know so far about coronavirus disease (COVID?19) in children.
CLINICAL CHARACTERISTICS
7/31/20
Akhtar H, Patel C, Abuelgasim E, et al. | Gynecol Obstet Invest
Aim: To review published studies related to the association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections with pregnancy, foetal, and neonatal outcomes during coronavirus disease 2019 (COVID-19) pandemic.
CLINICAL CHARACTERISTICS
7/30/20
Zhou Y, Yang Q, Chi J, et al. | Int J Infect Dis
Aim: To evaluate the association between different comorbidities and the severity of Covid-19.
CLINICAL CHARACTERISTICS
7/30/20
Figliozzi S, Masci P, Ahmadi N, et al. | Eur J Clin Invest
Aim: To review available evidence and provide pooled estimates on predictors of clinical outcomes in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/29/20
Yasuhara J, Kuno T, Takagi H, et al. | Pediatr Pulmonol
Aim: To investigate the clinical characteristics of COVID-19 in children.
CLINICAL CHARACTERISTICS
7/29/20
Liao S, Shao S, Chen Y, et al. | Crit Care
Aim: To review the evidence on severe complications of COVID-19 associated with coagulation changes, mainly characterized by increased D-dimer and fibrinogen levels with higher thrombosis risk, in particular pulmonary embolism (PE).
CLINICAL CHARACTERISTICS
7/28/20
Rao SN, Manissero D, Steele VR, et al. | Infect Dis Ther
Aim: To review available knowledge on correlations between SARS-COV-2 Ct values and patient- or healthcare-related outcomes to determine whether Ct values provide useful clinical information.
CLINICAL CHARACTERISTICS
7/28/20
Langford B, So M, Raybardhan S, et al. | Clin Microbiol Infect
Aim: To determine the prevalence of bacterial co-infection (at presentation) and secondary infection (after presentation) in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/28/20
Li X, Pan X, Li Y, et al. | Crit Care
Aim: To comprehensively evaluate the impact of cardiac injury and its related biomarkers on mortality and other prognosis in patients infected with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/28/20
Capobianco G, Saderi L, Aliberti S, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To assess the risk of clinical complications in pregnant women and neonates infected with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/28/20
Abdi A, Jalilian M, Sarbarzeh PA, et al. | Diabetes Res Clin Pract
Aim: To summarize the evidence about diabetes and COVID-19 outbreak through a systematic review and meta-analysis approach.
CLINICAL CHARACTERISTICS
7/28/20
Malik VS, Ravindra K, Attri SV, et al. | Environ Sci Pollut Res Int
Aim: To examine the emerging evidence to identify an association between body mass index (BMI) and COVID-19 disease outcome.
CLINICAL CHARACTERISTICS
7/28/20
Wu Y, Li H, Guo X, et al. | Hepatol Int
Aim: To explore the incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients.
CLINICAL CHARACTERISTICS
7/28/20
Kovalic AJ, Satapathy SK, Thuluvath PJ | Hepatol Int
Aim: To determine the prevalence of CLD in patients with COVID-19 and their clinical outcomes.
CLINICAL CHARACTERISTICS
7/28/20
Weiss A, Jellingso M, Sommer MOA | EBioMedicine
Aim: To conduct a coherent overview of the duration of viral detection and viral RNA load in COVID-19 patients, stratified by specimen type, clinical severity, and age.
CLINICAL CHARACTERISTICS
7/24/20
Lin J, Yan H, Chen H, et al. | J Med Virol
Aim: To review the blood coagulation indicators in severe COVID?19 patients.
CLINICAL CHARACTERISTICS
7/23/20
de Melo GC, de Araujo KCGM | Cad Saude Publica
Aim: To analyze whether COVID-19 in pregnant women is related to premature birth and birth weight, and to summarize the diagnostic results of neonates born to mothers with COVID-19 for investigating the possibility of vertical transmission.
CLINICAL CHARACTERISTICS
7/23/20
Taherifard E, Taherifard E | Neurol Res
Aim: To systematically review the neurological complications in patients with SARS-CoV-2 infection and the methods used to diagnose both neurological complications and coronavirus infection.
CLINICAL CHARACTERISTICS
7/23/20
Deniz M, Tezer H | J Matern Fetal Neonatal Med
Aim: To review the current evidence on the vertical transmission of SARS CoV-2.
CLINICAL CHARACTERISTICS
7/22/20
Chen X, Laurent S, Onur OA, et al. | J Neurol
Aim: To study the frequency of neurological symptoms and complications in COVID-19 patients in a systematic review of the literature.
CLINICAL CHARACTERISTICS
7/22/20
Sorrentino S, Cacia M, Leo I et al. | J Clin Med
Aim: To investigate whether the measurement of NT-proBNP may help discriminate clinical severity in patients with COVID-19
CLINICAL CHARACTERISTICS
7/21/20
Ashraf MA, Keshavarz P, Hosseinpour P, et al. | J Reprod Infertil
Aim: To demonstrate the effects of COVID-19 on pregnant women and the possibility of vertical transmission.
CLINICAL CHARACTERISTICS
7/21/20
Kovalic AJ, Huang G, Thuluvath PJ, et al. | Hepatology
Aim: To further characterize liver injury and other unique clinical characteristics across COVID-19 severity.
CLINICAL CHARACTERISTICS
7/21/20
Lim MA, Pranata R, Huang I, et al. | Can J Kidney Health Dis
Aim: To investigate the association between several complications, including acute kidney injury (AKI), acute liver injury (ALI), and coagulopathy, with poor outcomes in COVID-19.
CLINICAL CHARACTERISTICS
7/21/20
He J, Guo Y, Mao R, et al. | J Med Virol
Aim: To systematically review the characteristics of asymptomatic infection in the coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
7/21/20
Kumar J, Meena J, Yadav A, et al. | J Trop Pediatr
Aim: To compile the radiological findings of COVID-19 pneumonia in children in a systematic manner.
CLINICAL CHARACTERISTICS
7/21/20
Bajwa H, Riaz Y, Ammar M, et al. | Cureus
Aim: To analyze the published data on kidney injuries in COVID-19 and mortality rates in these patients.
CLINICAL CHARACTERISTICS
7/20/20
Gao Y, Liu M, Chen Y, et al. | J Med Virol
Aim: To assess whether tuberculosis is associated with an increased risk of severe disease and death in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/20/20
Egbert AR, Cankurtaran S, Karpiak S | Brain Behav Immun
Aim: To synthesize early data on typology and topography of brain abnormalities in adults with COVID-19 in acute/subacute phase.
CLINICAL CHARACTERISTICS
7/20/20
Tian Y, Qiu X, Wang C, et al. | Int J Cancer
Aim: To review the evidence on cancer prevalence in patients with COVID-19, and examine the association of cancer with severe events.
CLINICAL CHARACTERISTICS
7/20/20
Pei Y, Liu W, Masokano IB, et al. | J Infect Public Health
Aim: To investigate the differences in the clinical manifestations and imaging characteristics between Chinese children and adults with COVID-19 by systematically analyzing the data derived from some latest literatures.
CLINICAL CHARACTERISTICS
7/19/20
Pormohammad A, Ghorbani S, Baradaran B, et al. | Microb Pathog
Aim: To evaluate the clinical features and laboratory findings using a large sample size of COVID-19 infected patients in order to assist in its understanding, prevention and treatment.
UPDATED
CLINICAL CHARACTERISTICS
7/19/20
Zarifian A, Birdary MZ, Arekhi S, et al. | J Med Virol
Aim: To review the evidence on gastrointestinal and liver manifestations of COVID-19 patients.
CLINICAL CHARACTERISTICS
7/19/20
Chen Y, Shao S, Lai EC, et al. | Crit Care
Aim: To compare the mortality rate in patients with SARS, MERS, and COVID-19 who developed acute kidney injury.
CLINICAL CHARACTERISTICS
7/19/20
Abdullahi A, Candan SA, Abba MA, et al. | Front Neurol
Aim: To summarize the evidence on the neurological and musculoskeletal symptoms of the disease.
CLINICAL CHARACTERISTICS
7/19/20
Foldi M, Farkas N, Kiss S, et al. | Obes Rev
Aim: To examine whether obesity is a risk factor for the critical condition in COVID?19 patients by performing a meta?analysis.
CLINICAL CHARACTERISTICS
7/18/20
Cooper TJ, Woodward BL, Harky A | HIV Med
Aim: To systematically review current studies reporting on clinical outcomes in people living with HIV (PLHIV) infected with severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2).
CLINICAL CHARACTERISTICS
7/18/20
Ghayda RA, Lee J, Lee JY, et al. | Int J Environ Res Public Health
Aim: To perform a novel systematic review and meta-analysis focusing on findings about correlations between clinical characteristics and laboratory features of patients with COVID-19.
CLINICAL CHARACTERISTICS
7/18/20
Yadav DK, Singh A, Zhang Q, et al. | Gut
Aim: To perform a meta-analysis to estimate the prognosis of patients with COVID-19 stratified according to liver injury. 
CLINICAL CHARACTERISTICS
7/17/20
Galbadage T, Peterson BM, Awada J, et al. | Front Med
Aim: To examine the association between male sex and COVID-19 severity.
UPDATED
CLINICAL CHARACTERISTICS
7/16/20
Liu J, Cui M, Yang T, et al. | BMJ Open Gastroenterol
Aim: To study the correlation between gastrointestinal (GI) symptoms and disease severity in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/16/20
Shah S, Shah K, Patel SB, et al. | Cardiol Rev
Aim: To investigate the prognostic role of D-dimer in COVID-19 infected patients. 
UPDATED
CLINICAL CHARACTERISTICS
7/15/20
Zaki N, Alashwal H, Ibrahim S | Diabetes Metab Syndr
Aim: To undertake a review and critical appraisal of published/preprint reports that offer methods of determining the effects of hypertension, diabetes, stroke, cancer, kidney issues, and high-cholesterol on COVID-19 disease severity. 
CLINICAL CHARACTERISTICS
7/15/20
Collantes ME, Espiritu AI, Sy MCC, et al. | Can J Neurol Sci
Aim: To determine the neurological 48 manifestations and complications in COVID-19.
CLINICAL CHARACTERISTICS
7/15/20
Slyk S, Domitrz I | Neurol Neurochir Pol
Aim: To assess the neurological manifestations of SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/14/20
Patel RS, Patel N, Baksh M, et al. | Cureus
Aim: To summarize the transmission and pathology of 2019-nCoV, and demographics, clinical presentation, laboratory, and chest imaging findings, along with treatment and outcomes in 2019-nCoV pneumonia patients.
CLINICAL CHARACTERISTICS
7/14/20
Fang X, Li S, Yu H, et al. | Aging
Aim: To systematically collect and evaluate the associations of epidemiological, comorbidity factors with the severity and prognosis of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
7/14/20
Bajgain KT, Badal S, Bajgain BB, et al. | Am J Infect Control
Aim: To explore the prevalence of top global comorbidities (CVD, Diabetes, COPD, Cancer, and CKD) among individuals with COVID-19, as well as investigate any significant associations.
CLINICAL CHARACTERISTICS
7/13/20
Momtazmanesh S, Shobeiri P, Hanaei S, et al. | Egypt Heart J
Aim: To define the clinical, electrocardiographic, and pathologic spectrum of cardiovascular disease (CVD), frequency of elevated cardiac and inflammatory biomarkers, and their frequency and relationship with severity of the disease and mortality in COVID-19 patients and to develop a triage risk stratification tool (TRST) that can serve as a guide for the timely recognition of the high-risk patients and mechanism-targeted therapy. 
CLINICAL CHARACTERISTICS
7/13/20
Tan Y, Goh C, Leow AST, et al. | J Thromb Thrombolysis
Aim: To characterize the clinical characteristics, neuroimaging findings, and outcomes of AIS in COVID-19 patients. 
CLINICAL CHARACTERISTICS
7/13/20
Nepal G, Rehrig JH, Shrestha GS, et al. | Crit Care
Aim: To inform and improve decision-making among the physicians treating COVID-19 by presenting a systematic analysis of the neurological manifestations experienced within these patients.
CLINICAL CHARACTERISTICS
7/13/20
Manabe T, Akatsu H, Kotani K, et al. | Respir Investig
Aim: To elucidate the clinical features of COVID-19 using a meta-analysis with a stratified analysis according to the timeline and the changes in the exposure risks before the disease was declared as a pandemic.
CLINICAL CHARACTERISTICS
7/11/20
Shafi AMA, Shaikh SA, Shirke MM, et al. | J Card Surg
Aim: To systematically review the current published literature on the different cardiac manifestations and the use of cardiac?specific biomarkers in terms of their prognostic value in determining clinical outcomes and correlation to disease severity.
CLINICAL CHARACTERISTICS
7/11/20
Abate S, Ali S, Mantedafro B, et al. | PLoS One
Aim: To investigate the rate of ICU admission, mortality, morbidity, and complications among patients with coronavirus.
UPDATED
CLINICAL CHARACTERISTICS
7/11/20
Moreno G, Carbonell R, Bodi M, et al. | Med Intensiva
Aim: To define the role of D-dimer in the disease, the prevalence of DIC and the usefulness of anticoagulant treatment in these patients.
CLINICAL CHARACTERISTICS
7/10/20
Arca KN, Smith JH, Chiang C, et al. | Headache
Aim: To summarize the current literature on non?steroidal anti?inflammatory drug and corticosteroid use during the coronavirus disease 2019 (COVID?19) pandemic.
CLINICAL CHARACTERISTICS
7/10/20
Kunutsor S, Laukkanen J | Ann Med
Aim: To evaluate renal complications of COVID-19 and their incidence using a systematic meta-analysis.
UPDATED
CLINICAL CHARACTERISTICS
7/9/20
Farsalinos K, Barbouni A, Poulas K, et al. | Ther Adv Chronic Dis
Aim: To examine the prevalence and effects of current smoking on adverse outcomes among hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
7/9/20
Trocado V, Silvestre-Machado J, Azevedo L, et al. | J Matern Fetal Neonatal Med
Aim: To evaluate the impact of COVID-19 during pregnancy.
CLINICAL CHARACTERISTICS
7/9/20
Fontana P, Casini A, Robert-Ebadi H, et al. | Swiss Med Wkly
Aim: To summarise the reported risk of VTE associated with COVID-19 infections and to summarise guidance documents on thromboprophylaxis in COVID-19 patients, in a systematic review.
CLINICAL CHARACTERISTICS
7/8/20
Lvliang L, Zhong W, Bian Z, et al. | J Infect
Aim: To compare mortality risk factors of COVID-19, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) to provide new strategies for COVID-19 prevention and treatment.
CLINICAL CHARACTERISTICS
7/8/20
Nandy K, Salunke A, Pathak SK, et al. | Diabetes Metab Syndr
Aim: To evaluate the impact of various morbidities on serious events in COVID 19.
CLINICAL CHARACTERISTICS
7/8/20
Seirafianpour F, Sodagar S, Mohammad AP, et al. | Dermatol Ther
Aim: To present an overview of suggestive skin manifestations of the COVID-19 and to address several considerations in the dermatological issues practices, during this pandemic.
CLINICAL CHARACTERISTICS
7/8/20
Kulkarni A, Kumar P, Tevethia HV, et al. | Aliment Pharmacol Ther
Aim: To assess the prevalence of CLD, the incidence of elevated liver chemistries and the outcomes of patients with and without underlying CLD/elevated liver chemistries in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/8/20
Pan D, Sze S, Minhas J, et al. | EClinicalMedicine
Aim: To assess whether ethnicity has been reported in patients with COVID-19 and its relation to clinical outcomes.
UPDATED
CLINICAL CHARACTERISTICS
7/7/20
Rokkas T | Ann Gastroenterol
Aim: To review the evidence on the involvement of the digestive system in COVID-19.
CLINICAL CHARACTERISTICS
7/6/20
Kumar-M P, Mishra S, Jha DK, et al. | Hepatol Int
Aim: To systematically study the occurrence of liver injury in COVID-19 and also determine the frequency of liver involvement in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/6/20
Borsetto D, Hopkins C, Philips V, et al. | Rhinology
Aim: To systematically assess the prevalence of self-reported altered sense of smell or taste in patients with confirmed SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
7/6/20
Al-Sadeq DW, Nasrallah GK | Int J Infect Dis
Aim: To systematically review the published literature on SARS-CoV-2 in the asymptomatic patients to estimate the incidence of COVID-19 among asymptomatic cases, as well as describe its epidemiological and clinical significance.
CLINICAL CHARACTERISTICS
7/4/20
Aziz M, Fatima R, Haghbin H, et al. | Inflamm Bowel Dis
Aim: To better understand the incidence and outcomes of COVID-19 in infammatory bowel disease (IBD) patients.
CLINICAL CHARACTERISTICS
7/2/20
Potere N, Valeriani E, Candeloro M, et al. | Crit Care
Aim: To summarize the evidence on clinically relevant outcomes in hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
7/1/20
Altmayer S, Zanon M, Pacini GS, et al. | Eur Radiol
Aim: To compare the chest computed tomography (CT) findings of coronavirus disease 2019 (COVID-19) to other non-COVID viral pneumonia.
CLINICAL CHARACTERISTICS
7/1/20
Koh J, Shah SU, Chua PEY, et al. | Front Med
Aim: To review the epidemiological and clinical characteristics of COVID-19 cases in the early phase of the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
7/1/20
Lansiaux E, Pebay PP, Picard J, et al. | Clin Pulmonary Med
Aim: To review the evidence on whether the past/current smoking status entails higher probability of a severe course of COVID-19 illness, as compared with having never smoked.
CLINICAL CHARACTERISTICS
7/1/20
Ahmed FT, Jabbar SS | J Glob Trends Pharmaceut Sci
Aim: To review the probable vertical transmission and neonatal outcomes in confirmed COVID-19 pregnant women.
CLINICAL CHARACTERISTICS
7/1/20
Katal S, Balakrishnan S, Gholamrexanezhad A | J Neuroradiol
Aim: To review the available imaging findings of patients diagnosed with neurological symptoms associated with coronavirus infections.
CLINICAL CHARACTERISTICS
6/30/20
Hu CLH, Raval M, Schnall JA, et al. | Pediatr Infect Dis J
Aim: To determine the average shedding times of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via the respiratory and gastrointestinal tracts in children.
CLINICAL CHARACTERISTICS
6/30/20
Khalili M, Karamouzian M, Nasiri N, et al. | Epidemiol Infect
Aim: To synthesize case fatality rate (CFR) among confirmed COVID-19 patients, incubation period, and time from onset of COVID-19 symptoms to first medical visit, intensive care unit (ICU) admission, recovery and death.
CLINICAL CHARACTERISTICS
6/30/20
Armstrong RA, Kane AD, Cook TM | Anaesthesia
Aim: To assess the reported ICU mortality for patients with confirmed COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
6/30/20
Momenzadeh M | Eurasia J Biosci
Aim: To review the evidence on the prevalence of diabetes, Hypertension and cardiovascular diseases in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/30/20
Tarakji B, Alali FM, Alenzi A, et al. | Open Access Maced J Med Sci
Aim: To highlight the most important clinical data only concerning on COVID to assess the prognosis of this new virus.
CLINICAL CHARACTERISTICS
6/29/20
Khalili M, Karamouzian M, Nasiri N et al. | Epidemiol Infect
Aim: To synthesise case fatality rate (CFR) among confirmed COVID-19 patients, incubation period and time from onset of COVID-19 symptoms to first medical visit, intensive care unit (ICU) admission, recovery, and death.
CLINICAL CHARACTERISTICS
6/28/20
Zhao Q, Fang X, Pang Z, et al. | J Eur Acad Dermatol Venereol
Aim: To gain an in-depth understanding of COVID-19 by summarizing publications related to the cutaneous manifestations of the disease and the ACE2 expression in skin tissues.
CLINICAL CHARACTERISTICS
6/27/20
Matar R, Oules B, Sohier P, et al. | J Eur Acad Dermatol Venereol
Aim: To analyze our experience in a French referral center and to perform a systematic review of the literature to evaluate the incidence and prognosis of cutaneous lesions observed in COVID?19 patients. 
CLINICAL CHARACTERISTICS
6/27/20
Gengler I, Wang JC, Speth MM, et al. | Laryngoscope Investig Otolaryngol
Aim: To synthesize existing scientific evidence on the role of sinonasal pathophysiology in COVID?19.
CLINICAL CHARACTERISTICS
6/26/20
Meena J, Yadav J, Saini L, et al. | Indian Pediatr
Aim: To synthesize the information on clinical manifestations, laboratory findings, and outcome of COVID-19 among the pediatric population.
CLINICAL CHARACTERISTICS
6/26/20
Feng X, Li S, Sun Q, et al. | Front Med
Aim: To explore the effect of risk factors on the severity of the disease, focusing on immune-inflammatory parameters, which represent the immune status of patients.
CLINICAL CHARACTERISTICS
6/26/20
da Costa KVT, Carnauba ATL, Rocha KW, et al. | Braz J Otorhinolaryngol
Aim: To identify evidence in the scientific literature about olfactory/gustatory disorders, their clinical presentation, prevalence and possible specific treatments associated with COVID-19.
CLINICAL CHARACTERISTICS
6/25/20
Tahvildari A, Arbabi M, Farsi Y, et al. | Front Med
Aim: To characterize the clinical, diagnostic, and treatment characteristics of patients presenting with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/24/20
Polak SB, Van Gool IC, Cohen D, et al. | Mod Pathol
Aim: To increase our understanding of COVID-19 pathophysiology by constructing a timeline and correlating histopathological findings with clinical stages of COVID-19. 
CLINICAL CHARACTERISTICS
6/24/20
Matar R, Alrahamani L, Monzer N, et al. | Clin Infect Dis
Aim: To describe the clinical characteristics and perinatal outcomes of COVID-19 in pregnancy.
CLINICAL CHARACTERISTICS
6/24/20
Trippella G, Ciarcia M, Ferrari M, et al. | Pathogens
Aim: To provide a comprehensive overview of all the available data regarding clinical features, outcomes, and management of pregnant women with COVID-19. 
CLINICAL CHARACTERISTICS
6/24/20
Pinzon RT, Wijaya VO, Buana RB, et al. | Front Neurol
Aim: To understand the neurologic characteristic of the disease and help physicians with early diagnosis and management.
CLINICAL CHARACTERISTICS
6/24/20
Grant MC, Geoghegan L, Arbyn M, et al. | PLoS One
Aim: To determine the prevalence of symptoms associated with COVID-19 worldwide.
CLINICAL CHARACTERISTICS
6/23/20
Baksh M, Ravat V, Zaidi A, et al. | Cureus
Aim: To summarize the clinical presentation, laboratory and chest imaging findings, management protocols, and outcome of ARDS in COVID-19-positive patients.
CLINICAL CHARACTERISTICS
6/23/20
Wang Z, Zhou Q, Wang C, et al. | Ann Transl Med
Aim: To review the clinical characteristics of children with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/23/20
Huang D, Lian X, Song F, et al. | Ann Transl Med
Aim: To identify and treat the severe and critical patients with COVID-19 is the key clinical problem to be solved.
CLINICAL CHARACTERISTICS
6/23/20
Perez-Lopez FR, Tajada M, Saviron-Cornudella R, et al. | Maturitas
Aim: To examine mortality rates related to coronavirus disease 2019 (COVID-19) by gender among European countries.
CLINICAL CHARACTERISTICS
6/23/20
Alnor A, Sandberg MB, Gils C, et al. | J Appl Lab Med
Aim: To examine which routine laboratory tests are associated with severe COVID-19 disease.
CLINICAL CHARACTERISTICS
6/23/20
Singh AK, Gillies CL, Singh R, et al. | Diabetes Obes Metab
Aim: To estimate the prevalence of both cardiometabolic and other co?morbidities in patients with COVID?19 infection, and to estimate the increased risk of severity and mortality in people with co?morbidities.
CLINICAL CHARACTERISTICS
6/22/20
Hoang MP, Kanjanaumporn J, Aeumjaturapat S, et al. | Asian Pac J Allergy Immunol
Aim: To review the associations of olfactory and gustatory dysfunctions with COVID-19 which will be useful for early diagnosis and self-isolation. 
CLINICAL CHARACTERISTICS
6/21/20
Kronbichler A, Kresse D, Yoon S, et al. | Int J Infect Dis
Aim: To summarize the presentation of asymptomatic COVID-19 infections.
CLINICAL CHARACTERISTICS
6/20/20
Shelmerdine S, Lovrenski J, Caro-Dominguez P, et al. | Pediatr Radiol
Aim: To systematically review available literature regarding imaging findings in paediatric cases of COVID-19.
CLINICAL CHARACTERISTICS
6/20/20
Raba AA, Abobaker A, Elgenaidi IS, et al. | Acta Pediatr
Aim: To evaluate the clinical characteristics of COVID?19 in neonates and children under one year of age.
CLINICAL CHARACTERISTICS
6/20/20
Yang X, Jin Y, Li R, et al. | Crit Care
Aim: To assess the prevalence of abnormal urine analysis and kidney dysfunction in COVID-19 patients and to determine the association of acute kidney injury (AKI) with the severity and prognosis of COVID-19 patients.
CLINICAL CHARACTERISTICS
6/20/20
Sacco G, Briere O, Asfar M, et al. | Geriatr Psychol Neurosychiatr Vieil
Aim: To identify, from international literature, the most common symptoms met in older adults infected with the SARS-CoV-2 virus.
CLINICAL CHARACTERISTICS
6/20/20
Xuefeng M, Shouseng L, Chen L, Zhuang L, et al. | J Med Virol
Aim: To investigate the clinical features of pediatric inpatients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/19/20
Latalska M, Mackiewicz J | Ann Agric Environ Med
Aim: To review the evidence of ocular pathologies in asymptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
6/18/20
Chen Y, Shao S, Hsu C, et al. | Crit Care
Aim: To quantify the incidence of acute kidney injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/18/20
Chung TW, Sridhar S, Zhang AZ, et al. | Open Forum Infect Dis
Aim: To review the evidence on olfactory disturbances in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/15/20
Souza, T, Nadal JA, Nogueira RJ, et al. | Pediatr Pulmonol
Aim: To describe the clinical, laboratorial and radiological characteristics of children with COVID-19. 
CLINICAL CHARACTERISTICS
6/15/20
Wang B, Huang Y | Crit Rev Oncol Hematol
Aim: To explore which type of cancer patients are more susceptible to the SARS-CoV-2.
CLINICAL CHARACTERISTICS
6/14/20
Velev V, Popov M, Velikov P, et al. | Infez Med
Aim: To describe the incidence and type of the gastrointestinal injury (GI) in COVID-19, as well as their prognostic value.
CLINICAL CHARACTERISTICS